{"ticker": {"uuid": "f122c6ce-687d-42fb-87f1-05f6399d9ae6", "symbol": "IBRX", "name": "Immunitybio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-07T03:27:39+00:00", "published_display": "07 Oct 2026 03:27", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Beat expectations"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002225, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.8, "age_days": 9.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-07T03:18:40+00:00", "published_display": "07 Oct 2026 03:18", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Positive analyst conviction", "Positive market reaction"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.02092, "evidence_share": 9.9, "evidence_share_display": "9.9", "freshness_pct": 11.3, "age_days": 9.4, "influence_label": "Medium", "evidence_strength": 49, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio director Cheryl Cohen sells $851,088 in shares", "summary": "ImmunityBio director Cheryl Cohen sold 81,056 shares of company stock for $851,088 on October 2, 2026, as part of a pre-established trading plan. Concurrently, she acquired 55,979 shares by exercising stock options valued at $166,817. These transactions occurred amidst significant stock performance, with ImmunityBio also recently securing marketing authorization in the UAE for its drug ANKTIVA.", "url": "https://www.investing.com/news/insider-trading-news/immunitybio-director-cheryl-cohen-sells-851088-in-shares-93CH-4935373", "source_link": "https://www.investing.com/news/insider-trading-news/immunitybio-director-cheryl-cohen-sells-851088-in-shares-93CH-4935373", "source_link_is_lookup": false, "source_name": "Investing.com", "published_at": "2026-10-06T22:32:07", "published_display": "06 Oct 2026 22:32", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 40, "tone_signals": ["Institutional or insider selling"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006796, "evidence_share": 3.2, "evidence_share_display": "3.2", "freshness_pct": 3.5, "age_days": 9.6, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio proposes 560,000-share sale: what it means for ImmunityBio stock", "summary": "ImmunityBio director Barry J. Simon has proposed selling 560,000 common shares, valued at $7.66 million, which were acquired through an open-market transaction in 2013. The biotechnology company, listed on Nasdaq under IBRX, is balancing rapid revenue growth\u2014with second-quarter net product revenue up 92% to $50.70 million\u2014against substantial operating losses, reporting a Q2 2026 net loss of $230.39 million. The proposed sale is a notice of intent and not a completed transaction.", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/immunitybio-proposes-560-000-share-sale-what-it-means-for-immunitybio/70238599", "source_link": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/immunitybio-proposes-560-000-share-sale-what-it-means-for-immunitybio/70238599", "source_link_is_lookup": false, "source_name": "AD HOC NEWS", "published_at": "2026-10-06T04:57:38", "published_display": "06 Oct 2026 04:57", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.031475, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 23.7, "age_days": 10.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Eyes Green Open Ahead Of Earnings \u2014 What Happened With Anktiva Over The Weekend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-06T00:52:41+00:00", "published_display": "06 Oct 2026 00:52", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.021914, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 23.2, "age_days": 10.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE9IZXRwVGdrdkR0T1kyZ0lxandNb2pfd3BiSEhkM1hXT2NnV2RSWTBHbEdudDJCeEJvTTQxb3F2TlloZ0xIVzdNN2dtYzM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE9IZXRwVGdrdkR0T1kyZ0lxandNb2pfd3BiSEhkM1hXT2NnV2RSWTBHbEdudDJCeEJvTTQxb3F2TlloZ0xIVzdNN2dtYzM?oc=5", "source_link_is_lookup": false, "source_name": "Timothy Sykes", "published_at": "2026-10-05T20:40:00+00:00", "published_display": "05 Oct 2026 20:40", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001426, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 10.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "An officer and director proposes selling 560,000 shares of ImmunityBio (NASDAQ: IBRX).", "summary": "ImmunityBio officer and director Barry J. Simon has proposed to sell 560,000 common shares of the company, with an aggregate market value of $7,657,760.00. The proposed sale is scheduled for October 5, 2026, and will be handled by The Charles Schwab Corporation on the NASDAQ exchange. This Form 144 filing indicates an open-market transaction for securities originally acquired on December 31, 2013.", "url": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-abc1556120da.html", "source_link": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-abc1556120da.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-05T18:57:38", "published_display": "05 Oct 2026 18:57", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Business expansion", "Institutional or insider selling"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001701, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 10.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Life Sciences", "Financial Markets"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T23:59:23+00:00", "published_display": "04 Oct 2026 23:59", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001108, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump\u2019s Cancer Panel Pick", "summary": "ImmunityBio (IBRX) stock experienced its best week in over seven months, driven by retail investor speculation following Michael Caputo's appointment to President Trump's Cancer Panel. Investors believe this could lead to broader access for Anktiva, ImmunityBio's flagship immunotherapy. The company is also awaiting an FDA decision in January 2027 for an expanded label for Anktiva in bladder cancer, and its regulatory footprint has expanded to 34 countries.", "url": "https://stocktwits.com/news-articles/markets/equity/ibrx-stock-retail-anktiva-boost-trump-cancer-panel-pick/cZDpKEmRB1C", "source_link": "https://stocktwits.com/news-articles/markets/equity/ibrx-stock-retail-anktiva-boost-trump-cancer-panel-pick/cZDpKEmRB1C", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T22:13:00", "published_display": "04 Oct 2026 22:13", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.04001, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 31.5, "age_days": 11.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Rally Not Over Yet? Chairman Says Trump Diplomacy Led To \u2018Amazing Results\u2019 For Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T20:58:52+00:00", "published_display": "04 Oct 2026 20:58", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00138, "evidence_share": 0.7, "evidence_share_display": "0.7", "freshness_pct": 1.7, "age_days": 11.7, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T00:22:23+00:00", "published_display": "04 Oct 2026 00:22", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.015806, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 17.5, "age_days": 12.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "A director proposes selling 81,056 ImmunityBio (IBRX) shares, including 55,979 from option exercises.", "summary": "ImmunityBio director Cheryl Cohen has proposed selling 81,056 common shares, valued at approximately $752,199.68, with an anticipated sale date of October 2, 2026. The proposed sale includes 55,979 shares from stock option exercises on the same date and 25,077 shares from restricted stock units acquired on June 6, 2019. This transaction is reported via a Form 144 filing, which outlines the conditions under which restricted or insider-held shares can be publicly resold.", "url": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-4a344016212e.html", "source_link": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-4a344016212e.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T20:25:37", "published_display": "02 Oct 2026 20:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000614, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.9, "age_days": 13.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Jefferies upgrades ImmunityBio stock to Strong Buy", "summary": "Jefferies has upgraded ImmunityBio stock to a Strong Buy rating, leading to an 11.77% price increase on October 2, 2026. Seven analysts have set an average target of USD 14.20, significantly above its current trading price, though analyst ratings are not unanimous. The company reported strong revenue growth in Q2 2026, driven by its lead immunotherapy ANKTIVA, but continues to face profitability challenges with a loss per share of USD 0.22.", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/jefferies-upgrades-immunitybio-stock-to-strong-buy/70216821", "source_link": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/jefferies-upgrades-immunitybio-stock-to-strong-buy/70216821", "source_link_is_lookup": false, "source_name": "AD HOC NEWS", "published_at": "2026-10-02T18:08:00", "published_display": "02 Oct 2026 18:08", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 74, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.009937, "evidence_share": 4.7, "evidence_share_display": "4.7", "freshness_pct": 4.1, "age_days": 13.8, "influence_label": "Medium", "evidence_strength": 49, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Stock Jumps: What's Going On?", "summary": "ImmunityBio (IBRX) shares have been steadily rising over the past several months, with its stock chart showing a consistent upward trend despite choppy trading. The stock recently saw a sharp increase from $8.25 to $10.12 in two trading days, though the specific news driving this surge is not yet confirmed. Investors are now watching whether the stock can maintain its position above the $10.12-$10.50 range, as it currently trades near this level, to determine the staying power of this recent move.", "url": "https://www.benzinga.com/trading-ideas/movers/26/10/62142450/immunitybio-stock-jumps-whats-going-on", "source_link": "https://www.benzinga.com/trading-ideas/movers/26/10/62142450/immunitybio-stock-jumps-whats-going-on", "source_link_is_lookup": false, "source_name": "Benzinga", "published_at": "2026-10-02T17:25:37", "published_display": "02 Oct 2026 17:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 62, "tone_signals": ["Positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001273, "evidence_share": 0.6, "evidence_share_display": "0.6", "freshness_pct": 0.8, "age_days": 13.9, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Climbs As Chairman Backs PDS Biotechnology PIPE", "summary": "ImmunityBio Inc. (IBRX) stock has climbed over 10% after its Executive Chairman, Patrick Soon-Shiong, backed a PIPE financing in PDS Biotechnology and joined its board. While the company states its fundamentals remain unchanged, traders are speculating on future collaborations and the expansion of Soon-Shiong's oncology ecosystem. This move is driving bullish sentiment and technical strength in IBRX, despite the company's significant losses and cash burn.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_10_02", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_10_02", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-10-02T16:32:00", "published_display": "02 Oct 2026 16:32", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.084104, "evidence_share": 39.7, "evidence_share_display": "39.7", "freshness_pct": 25.3, "age_days": 13.9, "influence_label": "Medium", "evidence_strength": 51, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna\u2019s Rally As MRNA Lands A Nasdaq-100 Spot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sls-ibrx-stocks-climb-overnight-070203292.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/sls-ibrx-stocks-climb-overnight-070203292.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-02T07:02:03+00:00", "published_display": "02 Oct 2026 07:02", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000453, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.7, "age_days": 14.3, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio (NasdaqGS:IBRX) Stock Forecast & Analyst Predictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNQUFMbE5tSlg4ODZnN1E0RUFhaHZGSUxwV3NIM2dLR3B5NWVlY0dmWGMzTHE1eFJLTlppRnBpWFpTaEFXNG5JT0hVQjFXU0VnVFI0cW1kV2RldmlLSVNJQnBoVzZfalFtX3UyQ1U1N0pWcWk5R3lMM0gtZHJOVmF2Ri1lVVVBd1Foc1B5czdlUQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNQUFMbE5tSlg4ODZnN1E0RUFhaHZGSUxwV3NIM2dLR3B5NWVlY0dmWGMzTHE1eFJLTlppRnBpWFpTaEFXNG5JT0hVQjFXU0VnVFI0cW1kV2RldmlLSVNJQnBoVzZfalFtX3UyQ1U1N0pWcWk5R3lMM0gtZHJOVmF2Ri1lVVVBd1Foc1B5czdlUQ?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-10-02T07:00:00+00:00", "published_display": "02 Oct 2026 07:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.027565, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 24.3, "age_days": 14.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX|Immunitybio Inc|Price:10.280|Chg%:-0.005", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzbjJrUlVjdXB2QzVQemJ1REE1eTRnblE5REllWDY0dlpZclJPUkttajFrZW9Bb0xTVnh6Zy1sWVBNMzdPMk96c1FWYU5SLXpVUjJhanNTU2hjdw?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzbjJrUlVjdXB2QzVQemJ1REE1eTRnblE5REllWDY0dlpZclJPUkttajFrZW9Bb0xTVnh6Zy1sWVBNMzdPMk96c1FWYU5SLXpVUjJhanNTU2hjdw?oc=5", "source_link_is_lookup": false, "source_name": "TradingKey", "published_at": "2026-10-02T07:00:00+00:00", "published_display": "02 Oct 2026 07:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 38, "tone_signals": ["Negative market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000777, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.7, "age_days": 14.3, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Shares Rise as Investors Revisit ANKTIVA Expansion and Revenue Momentum", "summary": "ImmunityBio shares increased as investors re-evaluated the company's prospects, particularly regarding the expansion of ANKTIVA and potential revenue growth. The article suggests renewed investor confidence in the company's future performance.", "url": "https://www.moomoo.com/news/post/1000491999/immunitybio-shares-rise-as-investors-revisit-anktiva-expansion-and-revenue", "source_link": "https://www.moomoo.com/news/post/1000491999/immunitybio-shares-rise-as-investors-revisit-anktiva-expansion-and-revenue", "source_link_is_lookup": false, "source_name": "Moomoo", "published_at": "2026-10-01T13:58:33", "published_display": "01 Oct 2026 13:58", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.020335, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 12.5, "age_days": 15.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Stock Analysis: Bullish Breakout in October", "summary": "ImmunityBio stock (IBRX) experienced a significant bullish breakout, closing up 6.91% at $9.44 and touching $10 intraday for the first time since March. Technical analysis indicates a strong bullish alignment across daily and hourly charts, supported by momentum indicators and institutional interest. While a short-term pullback is noted on the 15-minute chart for digestion, the overall evidence favors a continuation of the bullish trend, with key resistance levels at $9.48 and $10.05.", "url": "https://en.cryptonomist.ch/2026/10/01/immunitybio-stock-surges-6-91-to-close-at-9-44-touches-10-intraday-for-first-time-since-march", "source_link": "https://en.cryptonomist.ch/2026/10/01/immunitybio-stock-surges-6-91-to-close-at-9-44-touches-10-intraday-for-first-time-since-march", "source_link_is_lookup": false, "source_name": "The Cryptonomist", "published_at": "2026-10-01T11:25:00", "published_display": "01 Oct 2026 11:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 59, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000566, "evidence_share": 0.3, "evidence_share_display": "0.3", "freshness_pct": 0.5, "age_days": 15.1, "influence_label": "Low", "evidence_strength": 31, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ibrx-stock-racks-3-straight-031841554.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ibrx-stock-racks-3-straight-031841554.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-01T03:18:41+00:00", "published_display": "01 Oct 2026 03:18", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000223, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.5, "age_days": 15.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5tei1LTWtnRUtPSjMtX3lrc3QxTUxUY1huSC1VMVRKTm9scVpIMlY2RVEydmI3QWhET1ZMQkxzcVpPbHRYb0xYeW5nVUM3dlU0?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5tei1LTWtnRUtPSjMtX3lrc3QxTUxUY1huSC1VMVRKTm9scVpIMlY2RVEydmI3QWhET1ZMQkxzcVpPbHRYb0xYeW5nVUM3dlU0?oc=5", "source_link_is_lookup": false, "source_name": "cnn.com", "published_at": "2026-09-30T20:15:38+00:00", "published_display": "30 Sep 2026 20:15", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.023884, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 21.0, "age_days": 15.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Holds Gains As Soon\u2011Shiong Expands Oncology Network", "summary": "ImmunityBio Inc. (IBRX) stock is trading up after its chairman, Patrick Soon-Shiong, expanded his oncology network by leading PIPE financing into PDS Biotechnology and joining its board. This strategic move, while not immediately changing ImmunityBio's fundamentals, signals a long-term strategy for collaboration within the oncology ecosystem. The stock's steady appreciation and strong intraday trends suggest institutional accumulation and interest from momentum traders.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30-2", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30-2", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-09-30T21:00:03", "published_display": "30 Sep 2026 21:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Business expansion"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000776, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.4, "age_days": 15.7, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Stock Analysis: Bullish Trend Today with Key Resistance", "summary": "ImmunityBio stock surged over 10% on Wednesday, reaching $9.735, indicating a bullish trend supported by strong EMA alignment and positive momentum indicators. While the daily and hourly charts confirm this bullish outlook, the 15-minute chart suggests a potential short-term pause due to overbought conditions. Key resistance levels are identified at $10.24, with the $9.57\u2013$9.74 pivot zone acting as crucial support.", "url": "https://en.cryptonomist.ch/2026/09/30/immunitybio-stock-surges-over-10-to-9-735-as-daily-trend-turns-bullish", "source_link": "https://en.cryptonomist.ch/2026/09/30/immunitybio-stock-surges-over-10-to-9-735-as-daily-trend-turns-bullish", "source_link_is_lookup": false, "source_name": "The Cryptonomist", "published_at": "2026-09-30T18:25:03", "published_display": "30 Sep 2026 18:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 68, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000765, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.4, "age_days": 15.8, "influence_label": "Medium", "evidence_strength": 42, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Breaks Above This Key Resistance \u2014 Stock On Track To Record Best Single-Day Gains In 6 Months", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ibrx-breaks-above-key-resistance-163727688.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ibrx-breaks-above-key-resistance-163727688.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T16:37:27+00:00", "published_display": "30 Sep 2026 16:37", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000451, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.4, "age_days": 15.9, "influence_label": "Medium", "evidence_strength": 39, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send?", "summary": "ImmunityBio Inc. (IBRX) stock rose by 11.15% due to strong commercial momentum for its immunotherapy ANKTIVA, positive analyst sentiment, and strategic corporate developments. Wall Street analysts maintain a bullish consensus with an average price target of $12.75. Despite this, the company faces risks including widening net losses, equity dilution, concentrated governance, and regulatory execution risk.", "url": "https://www.tradingkey.com/news/market-movers/262194672-market-movers-ibrx-20260930", "source_link": "https://www.tradingkey.com/news/market-movers/262194672-market-movers-ibrx-20260930", "source_link_is_lookup": false, "source_name": "TradingKey", "published_at": "2026-09-30T17:25:03", "published_display": "30 Sep 2026 17:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 56, "tone_signals": ["Positive financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003199, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 2.6, "age_days": 15.9, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Grinds Higher As Chairman Expands Oncology Reach", "summary": "ImmunityBio Inc. (IBRX) stock has been steadily rising, driven by investor optimism following pivotal trial success and strategic moves by its Executive Chairman, Patrick Soon-Shiong. Soon-Shiong is leading a PIPE financing into PDS Biotechnology and joining its board, expanding his oncology ecosystem and potentially fostering future collaborations for ImmunityBio's cancer pipeline. Despite significant financial losses and cash burn, IBRX's strong liquidity and the positive market reaction to these strategic developments are fueling its momentum, making it a \"story stock\" for active traders.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-09-30T16:25:03", "published_display": "30 Sep 2026 16:25", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 61, "tone_signals": ["Positive financial language"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.041421, "evidence_share": 19.6, "evidence_share_display": "19.6", "freshness_pct": 20.7, "age_days": 15.9, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "A $5.8B Cancer Market Opportunity Is Emerging \u2014 Why GA-Courtenay Favors ImmunityBio (IBRX)", "summary": "The GA-Courtenay Special Situations Fund is an investment fund managed by Green Ash Partners. The fund focuses on special situations and high-growth equities. You can download the July letter here. The fund reported a 13.8% decline in July, bringing its year-to-date performance to -10.0%. The fund attributed the decline to an unusual liquidity-driven dislocation across higher-growth stocks rather than deterioration in the fundamentals of its portfolio companies. Despite the volatility, merger arbitrage investments contributed positively, while equity gross exposure was reduced to 100% of NAV a", "url": "https://finance.yahoo.com/healthcare/articles/5-8b-cancer-market-opportunity-122830471.html", "source_link": "https://finance.yahoo.com/healthcare/articles/5-8b-cancer-market-opportunity-122830471.html", "source_link_is_lookup": false, "source_name": "Insider Monkey", "published_at": "2026-09-30T12:28:30+00:00", "published_display": "30 Sep 2026 12:28", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Strategic partnership"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000194, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.4, "age_days": 16.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Immunotherapy"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Biotech Lagged The Broader Market In September \u2014 Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI\u2019s Slump?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/biotech-lagged-broader-market-september-034757461.html", "source_link": "https://finance.yahoo.com/healthcare/articles/biotech-lagged-broader-market-september-034757461.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T03:47:57+00:00", "published_display": "30 Sep 2026 03:47", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000216, "evidence_share": 0.1, "evidence_share_display": "0.1", "freshness_pct": 0.3, "age_days": 16.4, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales \u2013 IBRX Stock Gains 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T02:44:21+00:00", "published_display": "30 Sep 2026 02:44", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.013139, "evidence_share": 6.2, "evidence_share_display": "6.2", "freshness_pct": 10.2, "age_days": 16.5, "influence_label": "Low", "evidence_strength": 34, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Inc Revenue Breakdown \u2013 HAN:26CA", "summary": "ImmunityBio Inc (HAN:26CA) generated 96.46 million EUR in revenue last year, primarily from its Immunotherapies segment. The United States was the largest contributor to this revenue, accounting for 96.22 million EUR. This represents a significant increase from the previous year's figures of 14.24 million EUR for Immunotherapies and 13.73 million EUR from the US.", "url": "https://www.tradingview.com/symbols/HAN-26CA/financials-segments", "source_link": "https://www.tradingview.com/symbols/HAN-26CA/financials-segments", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-29T13:23:03", "published_display": "29 Sep 2026 13:23", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.010416, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 9.4, "age_days": 17.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-29T02:29:12+00:00", "published_display": "29 Sep 2026 02:29", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 8.9, "age_days": 17.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Rally Not Over Yet? Chairman Says Trump Diplomacy Led To \u2018Amazing Results\u2019 For Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-29T01:23:11+00:00", "published_display": "29 Sep 2026 01:23", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000193, "evidence_share": 0.1, "evidence_share_display": "<0.1", "freshness_pct": 0.2, "age_days": 17.5, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-28T23:38:06+00:00", "published_display": "28 Sep 2026 23:38", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Beat expectations"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000138, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock To Open Week On A High? Chairman Teases Anktiva\u2019s 3-Year Expansion Plans, Hints At Cancer Breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-28T21:34:37+00:00", "published_display": "28 Sep 2026 21:34", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000134, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-26T21:17:35+00:00", "published_display": "26 Sep 2026 21:17", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 6.7e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 19.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for ImmunityBio Inc. (IBRX) stock, showing its current price and daily change. It also includes information on analyst ratings (currently unavailable) and earnings (no information provided). The article is presented within a trading education platform, cautioning readers about the risks and low profitability rates associated with day trading.", "url": "https://timothysykes.com/quote/IBRX", "source_link": "https://timothysykes.com/quote/IBRX", "source_link_is_lookup": false, "source_name": "timothysykes.com", "published_at": "2026-09-26T13:22:54", "published_display": "26 Sep 2026 13:22", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006872, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.2, "age_days": 20.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Is ImmunityBio (IBRX) A Bargain As Turkey Expansion Fuels Fresh Growth Hopes?", "summary": "ImmunityBio (IBRX) shares climbed nearly 10% following its founder\u2019s meeting with the Turkish President, signaling expansion into Turkey\u2019s cancer care market. Despite a recent cool-off in momentum, the company's valuation storyline pegs its fair value at $13 per share, significantly above its current trading price of $8.64, driven by ambitious expectations for its cancer and immunology pipeline and global expansion of ANKTIVA. The article explores whether the current price fairly reflects ImmunityBio's story, considering both its growth potential and inherent risks.", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-immunitybio-ibrx-a-bargain-as-turkey-expansion-fuels-fres/amp", "source_link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-immunitybio-ibrx-a-bargain-as-turkey-expansion-fuels-fres/amp", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-25T09:26:25", "published_display": "25 Sep 2026 09:26", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 53, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5.9e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History", "summary": "This article provides a comprehensive overview of ImmunityBio, Inc. (IBRX), a biotechnology company focused on immunotherapies for cancer and infectious diseases. It details the company's stock performance, key financial metrics, earnings trends, analyst ratings, and product pipeline, including its FDA-approved drug Anktiva. The information is current as of September 25, 2026, with financial data up to Q2 FY26.", "url": "https://ca.finance.yahoo.com/quote/IBRX", "source_link": "https://ca.finance.yahoo.com/quote/IBRX", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-09-24T16:26:25", "published_display": "24 Sep 2026 16:26", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Contract or approval won"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.007956, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.8, "age_days": 21.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer", "summary": "ImmunityBio, Inc. participated in the World Bladder Cancer Patient Forum 2026 in Hong Kong to advocate for patient-centric clinical trial design in bladder cancer. Anjali Malhotra from ImmunityBio joined a panel to discuss the importance of involving patients in research development. This initiative highlights the company's commitment to advancing bladder cancer care and advocacy globally.", "url": "https://oncodaily.com/societies/immunitybio-inc-592275", "source_link": "https://oncodaily.com/societies/immunitybio-inc-592275", "source_link_is_lookup": false, "source_name": "Oncodaily", "published_at": "2026-09-23T18:44:03", "published_display": "23 Sep 2026 18:44", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.6e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 22.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate", "summary": "This article from CryptoRank.io discusses the current lack of a live exchange rate for ImmunityBio, Inc. Tokenized Stock (Robinhood) (IBRX) to Euro (EUR). It notes that no price data is available, likely due to the cryptocurrency not being traded or having very low trading volume. The article also touches on various factors that could affect the token's price once it becomes active.", "url": "https://cryptorank.io/price/immunitybio-inc-tokenized-stock-robinhood/eur", "source_link": "https://cryptorank.io/price/immunitybio-inc-tokenized-stock-robinhood/eur", "source_link_is_lookup": false, "source_name": "CryptoRank", "published_at": "2026-09-23T12:44:03", "published_display": "23 Sep 2026 12:44", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.4e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 23.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Blockchain", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%", "summary": "ImmunityBio Inc. (IBRX) shares jumped 9.94% after its founder, Dr. Patrick Soon-Shiong, met with Turkish President Recep Tayyip Erdogan, sparking optimism about the company's planned expansion into Turkey. This expansion follows the FDA approval and international acceptance of its immunotherapy drug Anktiva in 34 countries. The company also reported strong Q2 revenues, nearly doubling year-over-year, and increased institutional investor conviction.", "url": "https://www.insidermonkey.com/news/immunitybio-ibrx-meeting-with-turkish-president-fuels-expansion-hopes-shares-climb-10-1842501?amp=1", "source_link": "https://www.insidermonkey.com/news/immunitybio-ibrx-meeting-with-turkish-president-fuels-expansion-hopes-shares-climb-10-1842501?amp=1", "source_link_is_lookup": false, "source_name": "Insider Monkey", "published_at": "2026-09-22T20:26:00", "published_display": "22 Sep 2026 20:26", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 74, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.5e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 23.7, "influence_label": "Medium", "evidence_strength": 45, "duplicate_count": 2, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Could IBRX Be A Tokenized Stock? Founder\u2019s Tease Sends ImmunityBio Traders Into Speculation Mode", "summary": "ImmunityBio (IBRX) shares saw a surge after founder Patrick Soon-Shiong hinted at Nant's upcoming venture into blockchain-based stock trading, leading to speculation among retail traders that IBRX could become a tokenized stock. This speculation is fueled by the SEC's new \"Innovation Exemption\" which provides a five-year pathway for trading tokenized U.S.-listed securities. Nant is actively building a comprehensive blockchain trading platform to facilitate this new form of capital market.", "url": "https://fr.tradingview.com/news/stocktwits:905379cda094b:0-could-ibrx-be-a-tokenized-stock-founder-s-tease-sends-immunitybio-traders-into-speculation-mode", "source_link": "https://fr.tradingview.com/news/stocktwits:905379cda094b:0-could-ibrx-be-a-tokenized-stock-founder-s-tease-sends-immunitybio-traders-into-speculation-mode", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-21T12:44:03", "published_display": "21 Sep 2026 12:44", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 25.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 3, "topics": ["Blockchain", "Financial Markets", "Life Sciences", "Technology"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales \u2013 IBRX Stock Gains 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T21:30:44+00:00", "published_display": "19 Sep 2026 21:30", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003187, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 2.5, "age_days": 26.7, "influence_label": "Low", "evidence_strength": 32, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T19:56:54+00:00", "published_display": "19 Sep 2026 19:56", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Positive analyst conviction", "Positive market reaction"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000402, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.2, "age_days": 26.8, "influence_label": "Medium", "evidence_strength": 45, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Eyes Green Open Ahead Of Earnings \u2014 What Happened With Anktiva Over The Weekend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T18:33:43+00:00", "published_display": "19 Sep 2026 18:33", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002299, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 26.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock To Open Week On A High? Chairman Teases Anktiva\u2019s 3-Year Expansion Plans, Hints At Cancer Breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T10:45:04+00:00", "published_display": "19 Sep 2026 10:45", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 27.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last?", "summary": "ImmunityBio IBRX shares soared 7% in the last trading session to close at $8.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.7% loss over the past four weeks. Recently, ImmunityBio's founder and executive chairman, Dr. Patrick Soon-Shiong, through his investment vehicle Nant Capital, led an $11.3 million PIPE financing for small-cap biotech PDS Biotechnology. Alongside the financing, a Nant affiliate received a one-year exclusive right to negotiate a license for PDS0101, PDS's investigational HPV-targeted immu", "url": "https://finance.yahoo.com/markets/stocks/articles/immunitybio-ibrx-moves-7-0-074100937.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/immunitybio-ibrx-moves-7-0-074100937.html", "source_link_is_lookup": false, "source_name": "Zacks", "published_at": "2026-09-18T07:41:00+00:00", "published_display": "18 Sep 2026 07:41", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 28.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Biotech", "Earnings", "Earnings Estimate", "Immunotherapy", "Medical", "Revenue Growth"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Shareholders to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into ImmunityBio, Inc. (IBRX) for potential corporate wrongdoing. The firm encourages shareholders who purchased ImmunityBio securities before January 19, 2026, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to recover investor capital.", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1209961", "source_link": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1209961", "source_link_is_lookup": false, "source_name": "ACCESS Newswire", "published_at": "2026-09-17T21:37:55", "published_display": "17 Sep 2026 21:37", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 25, "tone_signals": ["Legal or regulatory risk"], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.021628, "evidence_share": 10.2, "evidence_share_display": "10.2", "freshness_pct": 5.8, "age_days": 28.7, "influence_label": "Medium", "evidence_strength": 54, "duplicate_count": 1, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}], "by_tier": {"direct": [{"title": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-07T03:27:39+00:00", "published_display": "07 Oct 2026 03:27", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "dbb9e343ce53602c1bc9877753a57b4dc5dfcff854d3584aa5055620bb3eca62", "target_scope": "IBRX Stock Extends 5-Day Losing Streak", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002225, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.8, "age_days": 9.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-07T03:18:40+00:00", "published_display": "07 Oct 2026 03:18", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "93646f378673495c969cef8244a27b83b816e64a7a4a0e98a1d675d0f3f1cd6f", "target_scope": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.7250000000000001, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Positive analyst conviction", "Positive market reaction"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.02092, "evidence_share": 9.9, "evidence_share_display": "9.9", "freshness_pct": 11.3, "age_days": 9.4, "influence_label": "Medium", "evidence_strength": 49, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio director Cheryl Cohen sells $851,088 in shares", "summary": "ImmunityBio director Cheryl Cohen sold 81,056 shares of company stock for $851,088 on October 2, 2026, as part of a pre-established trading plan. Concurrently, she acquired 55,979 shares by exercising stock options valued at $166,817. These transactions occurred amidst significant stock performance, with ImmunityBio also recently securing marketing authorization in the UAE for its drug ANKTIVA.", "url": "https://www.investing.com/news/insider-trading-news/immunitybio-director-cheryl-cohen-sells-851088-in-shares-93CH-4935373", "source_link": "https://www.investing.com/news/insider-trading-news/immunitybio-director-cheryl-cohen-sells-851088-in-shares-93CH-4935373", "source_link_is_lookup": false, "source_name": "Investing.com", "published_at": "2026-10-06T22:32:07", "published_display": "06 Oct 2026 22:32", "provider": "alphavantage", "providers": ["alphavantage"], "provider_symbol": "", "provider_symbols": ["IBRX"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Investing.com"], "source_kind": "publisher", "story_key": "640dd74b1630b9bd013185bf810efce61918611718b87e1e210ca77e1e90a240", "target_scope": "ImmunityBio director Cheryl Cohen sells $851,088 in shares ImmunityBio director Cheryl Cohen sold 81,056 shares of company stock for $851,088 on October 2, 2026, as part of a pre-established trading plan. These transactions occurred amidst significant stock performance, with ImmunityBio also recently securing marketing authorization in the UAE for its drug ANKTIVA.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.694, "provider_directional_mass": 0.1177, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 40, "tone_signals": ["Institutional or insider selling"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006796, "evidence_share": 3.2, "evidence_share_display": "3.2", "freshness_pct": 3.5, "age_days": 9.6, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio proposes 560,000-share sale: what it means for ImmunityBio stock", "summary": "ImmunityBio director Barry J. Simon has proposed selling 560,000 common shares, valued at $7.66 million, which were acquired through an open-market transaction in 2013. The biotechnology company, listed on Nasdaq under IBRX, is balancing rapid revenue growth\u2014with second-quarter net product revenue up 92% to $50.70 million\u2014against substantial operating losses, reporting a Q2 2026 net loss of $230.39 million. The proposed sale is a notice of intent and not a completed transaction.", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/immunitybio-proposes-560-000-share-sale-what-it-means-for-immunitybio/70238599", "source_link": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/immunitybio-proposes-560-000-share-sale-what-it-means-for-immunitybio/70238599", "source_link_is_lookup": false, "source_name": "AD HOC NEWS", "published_at": "2026-10-06T04:57:38", "published_display": "06 Oct 2026 04:57", "provider": "alphavantage", "providers": ["alphavantage"], "provider_symbol": "", "provider_symbols": ["IBRX"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["AD HOC NEWS"], "source_kind": "publisher", "story_key": "35bbef8e2872d1cdbc34a793ab034914763ee44e809efc10f10db01641a5014f", "target_scope": "ImmunityBio proposes 560,000-share sale: what it means for ImmunityBio stock ImmunityBio director Barry J. The biotechnology company, listed on Nasdaq under IBRX, is balancing rapid revenue growth\u2014with second-quarter net product revenue up 92% to $50.70 million\u2014against substantial operating losses, reporting a Q2 2026 net loss of $230.39 million.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5529999999999999, "provider_directional_mass": 0.149, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.39, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.031475, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 23.7, "age_days": 10.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Eyes Green Open Ahead Of Earnings \u2014 What Happened With Anktiva Over The Weekend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-06T00:52:41+00:00", "published_display": "06 Oct 2026 00:52", "provider": "google_news", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "e43242b572a92458371cb7a82e4035fc2cb951ae78e17a58e6cc05efd7a048d4", "target_scope": "IBRX Stock Eyes Green Open Ahead Of Earnings", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.021914, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 23.2, "age_days": 10.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE9IZXRwVGdrdkR0T1kyZ0lxandNb2pfd3BiSEhkM1hXT2NnV2RSWTBHbEdudDJCeEJvTTQxb3F2TlloZ0xIVzdNN2dtYzM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE9IZXRwVGdrdkR0T1kyZ0lxandNb2pfd3BiSEhkM1hXT2NnV2RSWTBHbEdudDJCeEJvTTQxb3F2TlloZ0xIVzdNN2dtYzM?oc=5", "source_link_is_lookup": false, "source_name": "Timothy Sykes", "published_at": "2026-10-05T20:40:00+00:00", "published_display": "05 Oct 2026 20:40", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Timothy Sykes"], "source_kind": "publisher", "story_key": "617d13f1018816cf9a1566b14c25430944b61d900818269787c108618ddab51e", "target_scope": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001426, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 10.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "An officer and director proposes selling 560,000 shares of ImmunityBio (NASDAQ: IBRX).", "summary": "ImmunityBio officer and director Barry J. Simon has proposed to sell 560,000 common shares of the company, with an aggregate market value of $7,657,760.00. The proposed sale is scheduled for October 5, 2026, and will be handled by The Charles Schwab Corporation on the NASDAQ exchange. This Form 144 filing indicates an open-market transaction for securities originally acquired on December 31, 2013.", "url": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-abc1556120da.html", "source_link": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-abc1556120da.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-05T18:57:38", "published_display": "05 Oct 2026 18:57", "provider": "alphavantage", "providers": ["alphavantage"], "provider_symbol": "", "provider_symbols": ["IBRX"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "bfc62dddc1fc9f62ea254cf45e93374a09014832686e4c34b05a5bb392ba42d0", "target_scope": "An officer and director proposes selling 560,000 shares of ImmunityBio (NASDAQ: IBRX). ImmunityBio officer and director Barry J.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.1011, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001701, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 10.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Life Sciences", "Financial Markets"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T23:59:23+00:00", "published_display": "04 Oct 2026 23:59", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "2d63f93adafc59f7e6aa8c63a1072780bc7630ea8718e42b2da871271837bb47", "target_scope": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001108, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump\u2019s Cancer Panel Pick", "summary": "ImmunityBio (IBRX) stock experienced its best week in over seven months, driven by retail investor speculation following Michael Caputo's appointment to President Trump's Cancer Panel. Investors believe this could lead to broader access for Anktiva, ImmunityBio's flagship immunotherapy. The company is also awaiting an FDA decision in January 2027 for an expanded label for Anktiva in bladder cancer, and its regulatory footprint has expanded to 34 countries.", "url": "https://stocktwits.com/news-articles/markets/equity/ibrx-stock-retail-anktiva-boost-trump-cancer-panel-pick/cZDpKEmRB1C", "source_link": "https://stocktwits.com/news-articles/markets/equity/ibrx-stock-retail-anktiva-boost-trump-cancer-panel-pick/cZDpKEmRB1C", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T22:13:00", "published_display": "04 Oct 2026 22:13", "provider": "alphavantage", "providers": ["alphavantage", "archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "b092c2e336fecd3397ebf40d2d9b06fbd25d5553b2b6cb380373bf9d40f69b16", "target_scope": "IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump\u2019s Cancer Panel Pick ImmunityBio (IBRX) stock experienced its best week in over seven months, driven by retail investor speculation following Michael Caputo's appointment to President Trump's Cancer Panel. Investors believe this could lead to broader access for Anktiva, ImmunityBio's flagship immunotherapy. but The company is also awaiting an FDA decision in January 2027 for an expanded label for Anktiva in bladder cancer, and its regulatory footprint has expanded to 34 countries.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.4353, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.04001, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 31.5, "age_days": 11.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Rally Not Over Yet? Chairman Says Trump Diplomacy Led To \u2018Amazing Results\u2019 For Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T20:58:52+00:00", "published_display": "04 Oct 2026 20:58", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "3be902fc096be4dfb66e0c9c3521797509c08aa115003f32bd199a613de0952f", "target_scope": "IBRX Stock Rally Not Over Yet?", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00138, "evidence_share": 0.7, "evidence_share_display": "0.7", "freshness_pct": 1.7, "age_days": 11.7, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-04T00:22:23+00:00", "published_display": "04 Oct 2026 00:22", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "6d70f882b3a8f27aa2ea4b15eece14b6aa6bc1f798cfa9fc44fbcbce4c5d1e24", "target_scope": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.015806, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 17.5, "age_days": 12.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "A director proposes selling 81,056 ImmunityBio (IBRX) shares, including 55,979 from option exercises.", "summary": "ImmunityBio director Cheryl Cohen has proposed selling 81,056 common shares, valued at approximately $752,199.68, with an anticipated sale date of October 2, 2026. The proposed sale includes 55,979 shares from stock option exercises on the same date and 25,077 shares from restricted stock units acquired on June 6, 2019. This transaction is reported via a Form 144 filing, which outlines the conditions under which restricted or insider-held shares can be publicly resold.", "url": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-4a344016212e.html", "source_link": "https://www.stocktitan.net/sec-filings/IBRX/144-immunity-bio-inc-sec-filing-4a344016212e.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T20:25:37", "published_display": "02 Oct 2026 20:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "5ef99e6ca3f027a4bb83d5a97e3aedb717cdd6466dc0524c10c2d8f3fa21fa3c", "target_scope": "A director proposes selling 81,056 ImmunityBio (IBRX) shares, including 55,979 from option exercises. ImmunityBio director Cheryl Cohen has proposed selling 81,056 common shares, valued at approximately $752,199.68, with an anticipated sale date of October 2, 2026.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.1053, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000614, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.9, "age_days": 13.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Jefferies upgrades ImmunityBio stock to Strong Buy", "summary": "Jefferies has upgraded ImmunityBio stock to a Strong Buy rating, leading to an 11.77% price increase on October 2, 2026. Seven analysts have set an average target of USD 14.20, significantly above its current trading price, though analyst ratings are not unanimous. The company reported strong revenue growth in Q2 2026, driven by its lead immunotherapy ANKTIVA, but continues to face profitability challenges with a loss per share of USD 0.22.", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/jefferies-upgrades-immunitybio-stock-to-strong-buy/70216821", "source_link": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/jefferies-upgrades-immunitybio-stock-to-strong-buy/70216821", "source_link_is_lookup": false, "source_name": "AD HOC NEWS", "published_at": "2026-10-02T18:08:00", "published_display": "02 Oct 2026 18:08", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["AD HOC NEWS"], "source_kind": "publisher", "story_key": "a2813f738c77f4684889de1789c527b0c57cb43d84adb41302714e22f7819755", "target_scope": "Jefferies upgrades ImmunityBio stock to Strong Buy Jefferies has upgraded ImmunityBio stock to a Strong Buy rating, leading to an 11.77% price increase on October 2, 2026.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.7350000000000001, "provider_directional_mass": 0.4795, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 74, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.009937, "evidence_share": 4.7, "evidence_share_display": "4.7", "freshness_pct": 4.1, "age_days": 13.8, "influence_label": "Medium", "evidence_strength": 49, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Stock Jumps: What's Going On?", "summary": "ImmunityBio (IBRX) shares have been steadily rising over the past several months, with its stock chart showing a consistent upward trend despite choppy trading. The stock recently saw a sharp increase from $8.25 to $10.12 in two trading days, though the specific news driving this surge is not yet confirmed. Investors are now watching whether the stock can maintain its position above the $10.12-$10.50 range, as it currently trades near this level, to determine the staying power of this recent move.", "url": "https://www.benzinga.com/trading-ideas/movers/26/10/62142450/immunitybio-stock-jumps-whats-going-on", "source_link": "https://www.benzinga.com/trading-ideas/movers/26/10/62142450/immunitybio-stock-jumps-whats-going-on", "source_link_is_lookup": false, "source_name": "Benzinga", "published_at": "2026-10-02T17:25:37", "published_display": "02 Oct 2026 17:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Benzinga"], "source_kind": "publisher", "story_key": "3dc6cd9d1bedf53b0d52ca4250cc54ad310a873f65a14fed023878e0d086b0d1", "target_scope": "ImmunityBio Stock Jumps: What's Going On? ImmunityBio (IBRX) shares have been steadily rising over the past several months, with its stock chart showing a consistent upward trend despite choppy trading.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.625, "provider_directional_mass": 0.4182, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 62, "tone_signals": ["Positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001273, "evidence_share": 0.6, "evidence_share_display": "0.6", "freshness_pct": 0.8, "age_days": 13.9, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Climbs As Chairman Backs PDS Biotechnology PIPE", "summary": "ImmunityBio Inc. (IBRX) stock has climbed over 10% after its Executive Chairman, Patrick Soon-Shiong, backed a PIPE financing in PDS Biotechnology and joined its board. While the company states its fundamentals remain unchanged, traders are speculating on future collaborations and the expansion of Soon-Shiong's oncology ecosystem. This move is driving bullish sentiment and technical strength in IBRX, despite the company's significant losses and cash burn.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_10_02", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_10_02", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-10-02T16:32:00", "published_display": "02 Oct 2026 16:32", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["StocksToTrade"], "source_kind": "publisher", "story_key": "3bb71ab7f56bf3507c0372106aa1b901c57c175b7410144585733b2500e97c13", "target_scope": "IBRX Stock Climbs As Chairman Backs PDS Biotechnology PIPE ImmunityBio Inc. (IBRX) stock has climbed over 10% after its Executive Chairman, Patrick Soon-Shiong, backed a PIPE financing in PDS Biotechnology and joined its board. but the company states its fundamentals remain unchanged, traders are speculating on future collaborations and the expansion of Soon-Shiong's oncology ecosystem. This move is driving bullish sentiment and technical strength in IBRX, despite the company's significant losses and cash burn.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.8160000000000001, "provider_directional_mass": 0.3921, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.132, "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.084104, "evidence_share": 39.7, "evidence_share_display": "39.7", "freshness_pct": 25.3, "age_days": 13.9, "influence_label": "Medium", "evidence_strength": 51, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna\u2019s Rally As MRNA Lands A Nasdaq-100 Spot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sls-ibrx-stocks-climb-overnight-070203292.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/sls-ibrx-stocks-climb-overnight-070203292.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-02T07:02:03+00:00", "published_display": "02 Oct 2026 07:02", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE", "MRNA", "SLS", "^GSPC"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "58ae5ae13de23e53edb6843526493c0947f17ac29022efe3db78eb9a983ae958", "target_scope": "SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna\u2019s Rally As MRNA Lands A Nasdaq-100 Spot", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000453, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.7, "age_days": 14.3, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio (NasdaqGS:IBRX) Stock Forecast & Analyst Predictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNQUFMbE5tSlg4ODZnN1E0RUFhaHZGSUxwV3NIM2dLR3B5NWVlY0dmWGMzTHE1eFJLTlppRnBpWFpTaEFXNG5JT0hVQjFXU0VnVFI0cW1kV2RldmlLSVNJQnBoVzZfalFtX3UyQ1U1N0pWcWk5R3lMM0gtZHJOVmF2Ri1lVVVBd1Foc1B5czdlUQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNQUFMbE5tSlg4ODZnN1E0RUFhaHZGSUxwV3NIM2dLR3B5NWVlY0dmWGMzTHE1eFJLTlppRnBpWFpTaEFXNG5JT0hVQjFXU0VnVFI0cW1kV2RldmlLSVNJQnBoVzZfalFtX3UyQ1U1N0pWcWk5R3lMM0gtZHJOVmF2Ri1lVVVBd1Foc1B5czdlUQ?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-10-02T07:00:00+00:00", "published_display": "02 Oct 2026 07:00", "provider": "google_news", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Simply Wall Street"], "source_kind": "publisher", "story_key": "4bef946378a0897986d0615862c24a81f06c438716094cc03f74fffa1d991819", "target_scope": "ImmunityBio (NasdaqGS:IBRX) Stock Forecast & Analyst Predictions", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.027565, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 24.3, "age_days": 14.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX|Immunitybio Inc|Price:10.280|Chg%:-0.005", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzbjJrUlVjdXB2QzVQemJ1REE1eTRnblE5REllWDY0dlpZclJPUkttajFrZW9Bb0xTVnh6Zy1sWVBNMzdPMk96c1FWYU5SLXpVUjJhanNTU2hjdw?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzbjJrUlVjdXB2QzVQemJ1REE1eTRnblE5REllWDY0dlpZclJPUkttajFrZW9Bb0xTVnh6Zy1sWVBNMzdPMk96c1FWYU5SLXpVUjJhanNTU2hjdw?oc=5", "source_link_is_lookup": false, "source_name": "TradingKey", "published_at": "2026-10-02T07:00:00+00:00", "published_display": "02 Oct 2026 07:00", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["TradingKey"], "source_kind": "publisher", "story_key": "65a6d9e795feece590106f477e7d8c4bb95ce928af7e7f50dbebe2e83fc131d4", "target_scope": "IBRX|Immunitybio Inc|Price:10.280|Chg%:-0.005", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.609, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 38, "tone_signals": ["Negative market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000777, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.7, "age_days": 14.3, "influence_label": "Low", "evidence_strength": 35, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Shares Rise as Investors Revisit ANKTIVA Expansion and Revenue Momentum", "summary": "ImmunityBio shares increased as investors re-evaluated the company's prospects, particularly regarding the expansion of ANKTIVA and potential revenue growth. The article suggests renewed investor confidence in the company's future performance.", "url": "https://www.moomoo.com/news/post/1000491999/immunitybio-shares-rise-as-investors-revisit-anktiva-expansion-and-revenue", "source_link": "https://www.moomoo.com/news/post/1000491999/immunitybio-shares-rise-as-investors-revisit-anktiva-expansion-and-revenue", "source_link_is_lookup": false, "source_name": "Moomoo", "published_at": "2026-10-01T13:58:33", "published_display": "01 Oct 2026 13:58", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Moomoo"], "source_kind": "publisher", "story_key": "e296709aa1721351419233ef41e327baa6ed97985b43982e627f5d0d5d7fdeac", "target_scope": "ImmunityBio Shares Rise as Investors Revisit ANKTIVA Expansion and Revenue Momentum ImmunityBio shares increased as investors re-evaluated the company's prospects, particularly regarding the expansion of ANKTIVA and potential revenue growth.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5920000000000001, "provider_directional_mass": 0.5461, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.020335, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 12.5, "age_days": 15.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Stock Analysis: Bullish Breakout in October", "summary": "ImmunityBio stock (IBRX) experienced a significant bullish breakout, closing up 6.91% at $9.44 and touching $10 intraday for the first time since March. Technical analysis indicates a strong bullish alignment across daily and hourly charts, supported by momentum indicators and institutional interest. While a short-term pullback is noted on the 15-minute chart for digestion, the overall evidence favors a continuation of the bullish trend, with key resistance levels at $9.48 and $10.05.", "url": "https://en.cryptonomist.ch/2026/10/01/immunitybio-stock-surges-6-91-to-close-at-9-44-touches-10-intraday-for-first-time-since-march", "source_link": "https://en.cryptonomist.ch/2026/10/01/immunitybio-stock-surges-6-91-to-close-at-9-44-touches-10-intraday-for-first-time-since-march", "source_link_is_lookup": false, "source_name": "The Cryptonomist", "published_at": "2026-10-01T11:25:00", "published_display": "01 Oct 2026 11:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["The Cryptonomist"], "source_kind": "publisher", "story_key": "d6342d9094015bf0cba75a2aa66e3d80cbe611265621a305859bc7b591413eb3", "target_scope": "ImmunityBio Stock Analysis: Bullish Breakout in October ImmunityBio stock (IBRX) experienced a significant bullish breakout, closing up 6.91% at $9.44 and touching $10 intraday for the first time since March.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5409999999999999, "provider_directional_mass": 0.4773, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 59, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000566, "evidence_share": 0.3, "evidence_share_display": "0.3", "freshness_pct": 0.5, "age_days": 15.1, "influence_label": "Low", "evidence_strength": 31, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ibrx-stock-racks-3-straight-031841554.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ibrx-stock-racks-3-straight-031841554.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-01T03:18:41+00:00", "published_display": "01 Oct 2026 03:18", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["BLK", "IBRX", "IBRX.ARCHIVE", "NTRS"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "7f83284d8f92e2aef806f216a93c8d7fb7e0ac680fb92c29d63e3a5675f3724f", "target_scope": "IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000223, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.5, "age_days": 15.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5tei1LTWtnRUtPSjMtX3lrc3QxTUxUY1huSC1VMVRKTm9scVpIMlY2RVEydmI3QWhET1ZMQkxzcVpPbHRYb0xYeW5nVUM3dlU0?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5tei1LTWtnRUtPSjMtX3lrc3QxTUxUY1huSC1VMVRKTm9scVpIMlY2RVEydmI3QWhET1ZMQkxzcVpPbHRYb0xYeW5nVUM3dlU0?oc=5", "source_link_is_lookup": false, "source_name": "cnn.com", "published_at": "2026-09-30T20:15:38+00:00", "published_display": "30 Sep 2026 20:15", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["cnn.com"], "source_kind": "publisher", "story_key": "8d84e110426240db7de38d004c6d90d74e2d64cf43593848081a02936a26cbfb", "target_scope": "IBRX Stock Quote Price and Forecast", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.023884, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 21.0, "age_days": 15.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Holds Gains As Soon\u2011Shiong Expands Oncology Network", "summary": "ImmunityBio Inc. (IBRX) stock is trading up after its chairman, Patrick Soon-Shiong, expanded his oncology network by leading PIPE financing into PDS Biotechnology and joining its board. This strategic move, while not immediately changing ImmunityBio's fundamentals, signals a long-term strategy for collaboration within the oncology ecosystem. The stock's steady appreciation and strong intraday trends suggest institutional accumulation and interest from momentum traders.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30-2", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30-2", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-09-30T21:00:03", "published_display": "30 Sep 2026 21:00", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["StocksToTrade"], "source_kind": "publisher", "story_key": "ce991248f2eaee153e01528fa830656c37931f29215475fe9fa2bdb876a38838", "target_scope": "IBRX Stock Holds Gains As Soon\u2011Shiong Expands Oncology Network ImmunityBio Inc. (IBRX) stock is trading up after its chairman, Patrick Soon-Shiong, expanded his oncology network by leading PIPE financing into PDS Biotechnology and joining its board. not immediately changing ImmunityBio's fundamentals, signals a long-term strategy for collaboration within the oncology ecosystem.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.734, "provider_directional_mass": 0.3404, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Business expansion"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000776, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.4, "age_days": 15.7, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Stock Analysis: Bullish Trend Today with Key Resistance", "summary": "ImmunityBio stock surged over 10% on Wednesday, reaching $9.735, indicating a bullish trend supported by strong EMA alignment and positive momentum indicators. While the daily and hourly charts confirm this bullish outlook, the 15-minute chart suggests a potential short-term pause due to overbought conditions. Key resistance levels are identified at $10.24, with the $9.57\u2013$9.74 pivot zone acting as crucial support.", "url": "https://en.cryptonomist.ch/2026/09/30/immunitybio-stock-surges-over-10-to-9-735-as-daily-trend-turns-bullish", "source_link": "https://en.cryptonomist.ch/2026/09/30/immunitybio-stock-surges-over-10-to-9-735-as-daily-trend-turns-bullish", "source_link_is_lookup": false, "source_name": "The Cryptonomist", "published_at": "2026-09-30T18:25:03", "published_display": "30 Sep 2026 18:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["The Cryptonomist"], "source_kind": "publisher", "story_key": "cced0aa3870e4bc4720cbed14142ed382914f86261c0acab1817d6e9d99b7898", "target_scope": "ImmunityBio Stock Analysis: Bullish Trend Today with Key Resistance ImmunityBio stock surged over 10% on Wednesday, reaching $9.735, indicating a bullish trend supported by strong EMA alignment and positive momentum indicators.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.766, "provider_directional_mass": 0.5085, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 68, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000765, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 0.4, "age_days": 15.8, "influence_label": "Medium", "evidence_strength": 42, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Breaks Above This Key Resistance \u2014 Stock On Track To Record Best Single-Day Gains In 6 Months", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ibrx-breaks-above-key-resistance-163727688.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ibrx-breaks-above-key-resistance-163727688.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T16:37:27+00:00", "published_display": "30 Sep 2026 16:37", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "8370d21869de16d0f83a44bfcecd519da5eb6b1ee8f53b87c85ec60e480cf999", "target_scope": "IBRX Breaks Above This Key Resistance but Stock On Track To Record Best Single-Day Gains In 6 Months", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.5609999999999999, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000451, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.4, "age_days": 15.9, "influence_label": "Medium", "evidence_strength": 39, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send?", "summary": "ImmunityBio Inc. (IBRX) stock rose by 11.15% due to strong commercial momentum for its immunotherapy ANKTIVA, positive analyst sentiment, and strategic corporate developments. Wall Street analysts maintain a bullish consensus with an average price target of $12.75. Despite this, the company faces risks including widening net losses, equity dilution, concentrated governance, and regulatory execution risk.", "url": "https://www.tradingkey.com/news/market-movers/262194672-market-movers-ibrx-20260930", "source_link": "https://www.tradingkey.com/news/market-movers/262194672-market-movers-ibrx-20260930", "source_link_is_lookup": false, "source_name": "TradingKey", "published_at": "2026-09-30T17:25:03", "published_display": "30 Sep 2026 17:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["TradingKey"], "source_kind": "publisher", "story_key": "5d2d6008a6d00384ceef92cdf7c2d139e50b0441ff720d94395e8ac35da7f1b5", "target_scope": "Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send? ImmunityBio Inc. (IBRX) stock rose by 11.15% due to strong commercial momentum for its immunotherapy ANKTIVA, positive analyst sentiment, and strategic corporate developments.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.55, "provider_directional_mass": 0.8019, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 56, "tone_signals": ["Positive financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003199, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 2.6, "age_days": 15.9, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Grinds Higher As Chairman Expands Oncology Reach", "summary": "ImmunityBio Inc. (IBRX) stock has been steadily rising, driven by investor optimism following pivotal trial success and strategic moves by its Executive Chairman, Patrick Soon-Shiong. Soon-Shiong is leading a PIPE financing into PDS Biotechnology and joining its board, expanding his oncology ecosystem and potentially fostering future collaborations for ImmunityBio's cancer pipeline. Despite significant financial losses and cash burn, IBRX's strong liquidity and the positive market reaction to these strategic developments are fueling its momentum, making it a \"story stock\" for active traders.", "url": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30", "source_link": "https://stockstotrade.com/news/immunitybio-inc-ibrx-news-2026_09_30", "source_link_is_lookup": false, "source_name": "StocksToTrade", "published_at": "2026-09-30T16:25:03", "published_display": "30 Sep 2026 16:25", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["StocksToTrade"], "source_kind": "publisher", "story_key": "78ea481c0ed08fa0266e77ee6c974ea36a96fb805cf94ff0daa4890cfa81a9c3", "target_scope": "IBRX Stock Grinds Higher As Chairman Expands Oncology Reach ImmunityBio Inc. (IBRX) stock has been steadily rising, driven by investor optimism following pivotal trial success and strategic moves by its Executive Chairman, Patrick Soon-Shiong. Soon-Shiong is leading a PIPE financing into PDS Biotechnology and joining its board, expanding his oncology ecosystem and potentially fostering future collaborations for ImmunityBio's cancer pipeline. Despite significant financial losses and cash burn, IBRX's strong liquidity and the positive market reaction to these strategic developments are fueling its momentum, making it a \"story stock\" for active traders.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5429999999999999, "provider_directional_mass": 0.4935, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.183, "sentiment": "positive", "sentiment_pct": 61, "tone_signals": ["Positive financial language"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.041421, "evidence_share": 19.6, "evidence_share_display": "19.6", "freshness_pct": 20.7, "age_days": 15.9, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "A $5.8B Cancer Market Opportunity Is Emerging \u2014 Why GA-Courtenay Favors ImmunityBio (IBRX)", "summary": "The GA-Courtenay Special Situations Fund is an investment fund managed by Green Ash Partners. The fund focuses on special situations and high-growth equities. You can download the July letter here. The fund reported a 13.8% decline in July, bringing its year-to-date performance to -10.0%. The fund attributed the decline to an unusual liquidity-driven dislocation across higher-growth stocks rather than deterioration in the fundamentals of its portfolio companies. Despite the volatility, merger arbitrage investments contributed positively, while equity gross exposure was reduced to 100% of NAV a", "url": "https://finance.yahoo.com/healthcare/articles/5-8b-cancer-market-opportunity-122830471.html", "source_link": "https://finance.yahoo.com/healthcare/articles/5-8b-cancer-market-opportunity-122830471.html", "source_link_is_lookup": false, "source_name": "Insider Monkey", "published_at": "2026-09-30T12:28:30+00:00", "published_display": "30 Sep 2026 12:28", "provider": "archive", "providers": ["archive", "eodhd", "yfinance"], "provider_symbol": "IBRX.US", "provider_symbols": ["26CA.F", "IBRX", "IBRX.ARCHIVE", "IBRX.US"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Insider Monkey", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "8dab7d965bc23d6e545831c238b590f5eba40d7f709ceffa243cbc246be923d0", "target_scope": "Why GA-Courtenay Favors ImmunityBio (IBRX)", "durable_archive": false, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.88388, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000194, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.4, "age_days": 16.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Immunotherapy"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Biotech Lagged The Broader Market In September \u2014 Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI\u2019s Slump?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/biotech-lagged-broader-market-september-034757461.html", "source_link": "https://finance.yahoo.com/healthcare/articles/biotech-lagged-broader-market-september-034757461.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T03:47:57+00:00", "published_display": "30 Sep 2026 03:47", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE", "IOVA", "QQQ", "SLS", "SPY", "VNDA", "XBI", "^GSPC"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "90a4a40feb3757aa5224bb01fd0582a01e704cfb3958358fb1af80cadac49291", "target_scope": "Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI\u2019s Slump?", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000216, "evidence_share": 0.1, "evidence_share_display": "0.1", "freshness_pct": 0.3, "age_days": 16.4, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales \u2013 IBRX Stock Gains 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-30T02:44:21+00:00", "published_display": "30 Sep 2026 02:44", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "fa5e19a21e2a8ac68ebcb7c32b4157d3c035ce7f017d95ed01aa2ffa74535fed", "target_scope": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales IBRX Stock Gains 11%", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.013139, "evidence_share": 6.2, "evidence_share_display": "6.2", "freshness_pct": 10.2, "age_days": 16.5, "influence_label": "Low", "evidence_strength": 34, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "ImmunityBio Inc Revenue Breakdown \u2013 HAN:26CA", "summary": "ImmunityBio Inc (HAN:26CA) generated 96.46 million EUR in revenue last year, primarily from its Immunotherapies segment. The United States was the largest contributor to this revenue, accounting for 96.22 million EUR. This represents a significant increase from the previous year's figures of 14.24 million EUR for Immunotherapies and 13.73 million EUR from the US.", "url": "https://www.tradingview.com/symbols/HAN-26CA/financials-segments", "source_link": "https://www.tradingview.com/symbols/HAN-26CA/financials-segments", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-29T13:23:03", "published_display": "29 Sep 2026 13:23", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["TradingView"], "source_kind": "publisher", "story_key": "29e361fc94cf1123a47b627b49282565acf44ae4f68fbe70beab66f35f498307", "target_scope": "ImmunityBio Inc Revenue Breakdown ImmunityBio Inc (HAN:26CA) generated 96.46 million EUR in revenue last year, primarily from its Immunotherapies segment.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.3029, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.010416, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 9.4, "age_days": 17.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxOaFd5NGN0LUJlYzlCMnR4a3ZOa3Y1SHFJODU5clJEbTRseWt5c1pCaS1qSVNicndybDhQRmd0ME1QeUUxS3pmeDRzOUxhS1c2QWdiZFRrLUZmWUdXaDBDd29odFBYc2FDQktjcjNEeURRcE11clRHcXpQcXVqY3NOcUhkeXo3ckVvQVFnR2FBem41ck1HbWZIU2k2YnFZbFZGYlh2dERBb3dPWUZPbE5uV1NpUjg5RFl6Y3JDN204XzM0bGFGaHBaQWhoWDVQRV84S1pTYlZwYU1XaTlsdXN1ZEVlN3JpOV9xZHBHVmJtX2pGWGFwUTZFQm5xQmF0d2tGSDVWLTNFaTI2QQ?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-29T02:29:12+00:00", "published_display": "29 Sep 2026 02:29", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "6d70f882b3a8f27aa2ea4b15eece14b6aa6bc1f798cfa9fc44fbcbce4c5d1e24", "target_scope": "Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 8.9, "age_days": 17.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "IBRX Stock Rally Not Over Yet? Chairman Says Trump Diplomacy Led To \u2018Amazing Results\u2019 For Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcVFTb3RQWTZrUG9ONVN6MEVNSk54ckxoS1E2bWNXQmRjRWIxaURpT1lyY3ItODk1LXRGb0MyeWtSMERnRmpmNHpha1JPZWZWa1NUWmNkOGJNbjJiTWMtRm52djZJZTVhQUVmNDVHTUE0N1RtN2M5ZmxMSE9RbVVUTi1vZENNdHhTZWJ6eDFlZXhIUFI0Nm5rLTZYWUIwblZCaXRHYlhyd3Zpa25XcWUtbTNEdGVXelpqcVN0eDBZZ3RMajBVZjdxaVJYV3E4V2lMNnlUODhYMzdTR1h4NFRGWlQ4b01SNDluNEZvZXJjT29pTXpj?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-29T01:23:11+00:00", "published_display": "29 Sep 2026 01:23", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "3be902fc096be4dfb66e0c9c3521797509c08aa115003f32bd199a613de0952f", "target_scope": "IBRX Stock Rally Not Over Yet?", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000193, "evidence_share": 0.1, "evidence_share_display": "<0.1", "freshness_pct": 0.2, "age_days": 17.5, "influence_label": "Low", "evidence_strength": 29, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-28T23:38:06+00:00", "published_display": "28 Sep 2026 23:38", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "dbb9e343ce53602c1bc9877753a57b4dc5dfcff854d3584aa5055620bb3eca62", "target_scope": "IBRX Stock Extends 5-Day Losing Streak", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000138, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock To Open Week On A High? Chairman Teases Anktiva\u2019s 3-Year Expansion Plans, Hints At Cancer Breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-28T21:34:37+00:00", "published_display": "28 Sep 2026 21:34", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "2edea314facb9f0af2ec361b432824e0052683a9c3d3c296d0da4ea9c7e93128", "target_scope": "IBRX Stock To Open Week On A High?", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000134, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVXluaWo1TlVUVDFyY0huYjU5cEtnT2U3UEExNHZuaS1hT1FMamFBbUxmWFdpak5GOGN2NUxvakM1T3N2YUpfZmF5ZlJ6aTc5czRZNkhoYTQ5ZlVEdklkU0dnUG52Ujk5YmFfeWt3R0FscVdKRHR5UGVFeXdONTZWY1hFNWl4WUJ6RTlsQ3d5ZlhrZlNFaDNqSnR3SjlKRXNCZkRHNnVOOHE1eF80RmtYQms3WVVJeUVad1dv?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-26T21:17:35+00:00", "published_display": "26 Sep 2026 21:17", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "2d63f93adafc59f7e6aa8c63a1072780bc7630ea8718e42b2da871271837bb47", "target_scope": "IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 6.7e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 19.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for ImmunityBio Inc. (IBRX) stock, showing its current price and daily change. It also includes information on analyst ratings (currently unavailable) and earnings (no information provided). The article is presented within a trading education platform, cautioning readers about the risks and low profitability rates associated with day trading.", "url": "https://timothysykes.com/quote/IBRX", "source_link": "https://timothysykes.com/quote/IBRX", "source_link_is_lookup": false, "source_name": "timothysykes.com", "published_at": "2026-09-26T13:22:54", "published_display": "26 Sep 2026 13:22", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["timothysykes.com"], "source_kind": "publisher", "story_key": "617d13f1018816cf9a1566b14c25430944b61d900818269787c108618ddab51e", "target_scope": "ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ This page provides live quotes and charts for ImmunityBio Inc. (IBRX) stock, showing its current price and daily change. but It also includes information on analyst ratings (currently unavailable) and earnings (no information provided).", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.0964, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006872, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.2, "age_days": 20.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Is ImmunityBio (IBRX) A Bargain As Turkey Expansion Fuels Fresh Growth Hopes?", "summary": "ImmunityBio (IBRX) shares climbed nearly 10% following its founder\u2019s meeting with the Turkish President, signaling expansion into Turkey\u2019s cancer care market. Despite a recent cool-off in momentum, the company's valuation storyline pegs its fair value at $13 per share, significantly above its current trading price of $8.64, driven by ambitious expectations for its cancer and immunology pipeline and global expansion of ANKTIVA. The article explores whether the current price fairly reflects ImmunityBio's story, considering both its growth potential and inherent risks.", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-immunitybio-ibrx-a-bargain-as-turkey-expansion-fuels-fres/amp", "source_link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-immunitybio-ibrx-a-bargain-as-turkey-expansion-fuels-fres/amp", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-25T09:26:25", "published_display": "25 Sep 2026 09:26", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Simply Wall Street"], "source_kind": "publisher", "story_key": "08168441784ec2efeb26c8473e203ff2bebbd9914d86d92b6ecbb419a795872b", "target_scope": "Is ImmunityBio (IBRX) A Bargain As Turkey Expansion Fuels Fresh Growth Hopes? ImmunityBio (IBRX) shares climbed nearly 10% following its founder\u2019s meeting with the Turkish President, signaling expansion into Turkey\u2019s cancer care market. The article explores whether the current price fairly reflects ImmunityBio's story, considering both its growth potential and inherent risks.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.54, "provider_directional_mass": 0.3111, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 53, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5.9e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History", "summary": "This article provides a comprehensive overview of ImmunityBio, Inc. (IBRX), a biotechnology company focused on immunotherapies for cancer and infectious diseases. It details the company's stock performance, key financial metrics, earnings trends, analyst ratings, and product pipeline, including its FDA-approved drug Anktiva. The information is current as of September 25, 2026, with financial data up to Q2 FY26.", "url": "https://ca.finance.yahoo.com/quote/IBRX", "source_link": "https://ca.finance.yahoo.com/quote/IBRX", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-09-24T16:26:25", "published_display": "24 Sep 2026 16:26", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Yahoo! Finance Canada"], "source_kind": "publisher", "story_key": "7947df61fd79cd066911e4e0595e022b2b06321027caf541cb546d270c5a6d9e", "target_scope": "ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History This article provides a comprehensive overview of ImmunityBio, Inc. (IBRX), a biotechnology company focused on immunotherapies for cancer and infectious diseases. but It details the company's stock performance, key financial metrics, earnings trends, analyst ratings, and product pipeline, including its FDA-approved drug Anktiva.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.593, "provider_directional_mass": 0.346, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Contract or approval won"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.007956, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.8, "age_days": 21.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer", "summary": "ImmunityBio, Inc. participated in the World Bladder Cancer Patient Forum 2026 in Hong Kong to advocate for patient-centric clinical trial design in bladder cancer. Anjali Malhotra from ImmunityBio joined a panel to discuss the importance of involving patients in research development. This initiative highlights the company's commitment to advancing bladder cancer care and advocacy globally.", "url": "https://oncodaily.com/societies/immunitybio-inc-592275", "source_link": "https://oncodaily.com/societies/immunitybio-inc-592275", "source_link_is_lookup": false, "source_name": "Oncodaily", "published_at": "2026-09-23T18:44:03", "published_display": "23 Sep 2026 18:44", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Oncodaily"], "source_kind": "publisher", "story_key": "5d296d000b7098ff6247a541e094a3f0f31f354e4a2b947bc261298f2836fde5", "target_scope": "ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer ImmunityBio, Inc. participated in the World Bladder Cancer Patient Forum 2026 in Hong Kong to advocate for patient-centric clinical trial design in bladder cancer. Anjali Malhotra from ImmunityBio joined a panel to discuss the importance of involving patients in research development.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.482, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.6e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 22.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate", "summary": "This article from CryptoRank.io discusses the current lack of a live exchange rate for ImmunityBio, Inc. Tokenized Stock (Robinhood) (IBRX) to Euro (EUR). It notes that no price data is available, likely due to the cryptocurrency not being traded or having very low trading volume. The article also touches on various factors that could affect the token's price once it becomes active.", "url": "https://cryptorank.io/price/immunitybio-inc-tokenized-stock-robinhood/eur", "source_link": "https://cryptorank.io/price/immunitybio-inc-tokenized-stock-robinhood/eur", "source_link_is_lookup": false, "source_name": "CryptoRank", "published_at": "2026-09-23T12:44:03", "published_display": "23 Sep 2026 12:44", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["CryptoRank"], "source_kind": "publisher", "story_key": "3b39d96018bb9f2ce6b52455b36ed3c668d28ea0b9084c477963431aacbe231d", "target_scope": "ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate This article from CryptoRank.io discusses the current lack of a live exchange rate for ImmunityBio, Inc. Tokenized Stock (Robinhood) (IBRX) to Euro (EUR). but It notes that no price data is available, likely due to the cryptocurrency not being traded or having very low trading volume.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.007, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.4e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 23.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Blockchain", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%", "summary": "ImmunityBio Inc. (IBRX) shares jumped 9.94% after its founder, Dr. Patrick Soon-Shiong, met with Turkish President Recep Tayyip Erdogan, sparking optimism about the company's planned expansion into Turkey. This expansion follows the FDA approval and international acceptance of its immunotherapy drug Anktiva in 34 countries. The company also reported strong Q2 revenues, nearly doubling year-over-year, and increased institutional investor conviction.", "url": "https://www.insidermonkey.com/news/immunitybio-ibrx-meeting-with-turkish-president-fuels-expansion-hopes-shares-climb-10-1842501?amp=1", "source_link": "https://www.insidermonkey.com/news/immunitybio-ibrx-meeting-with-turkish-president-fuels-expansion-hopes-shares-climb-10-1842501?amp=1", "source_link_is_lookup": false, "source_name": "Insider Monkey", "published_at": "2026-09-22T20:26:00", "published_display": "22 Sep 2026 20:26", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news", "yfinance"], "provider_symbol": "", "provider_symbols": ["COIN", "IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Insider Monkey", "Market source"], "source_kind": "publisher", "story_key": "ab00525a60d86ad59f9c40c0d64cac4de87f9d5aae070884e0be9071e9e1b8bd", "target_scope": "ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10% ImmunityBio Inc. (IBRX) shares jumped 9.94% after its founder, Dr.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.825, "provider_directional_mass": 0.4194, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 74, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.5e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 23.7, "influence_label": "Medium", "evidence_strength": 45, "duplicate_count": 2, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Could IBRX Be A Tokenized Stock? Founder\u2019s Tease Sends ImmunityBio Traders Into Speculation Mode", "summary": "ImmunityBio (IBRX) shares saw a surge after founder Patrick Soon-Shiong hinted at Nant's upcoming venture into blockchain-based stock trading, leading to speculation among retail traders that IBRX could become a tokenized stock. This speculation is fueled by the SEC's new \"Innovation Exemption\" which provides a five-year pathway for trading tokenized U.S.-listed securities. Nant is actively building a comprehensive blockchain trading platform to facilitate this new form of capital market.", "url": "https://fr.tradingview.com/news/stocktwits:905379cda094b:0-could-ibrx-be-a-tokenized-stock-founder-s-tease-sends-immunitybio-traders-into-speculation-mode", "source_link": "https://fr.tradingview.com/news/stocktwits:905379cda094b:0-could-ibrx-be-a-tokenized-stock-founder-s-tease-sends-immunitybio-traders-into-speculation-mode", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-21T12:44:03", "published_display": "21 Sep 2026 12:44", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news", "yfinance"], "provider_symbol": "", "provider_symbols": ["COIN", "IBRX", "IBRX.ARCHIVE", "LLY", "META"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["Market source", "Stocktwits", "TradingView"], "source_kind": "publisher", "story_key": "4852bc2192b4481e771a9777173ba361d80d922354576944105c7fa04edea1a6", "target_scope": "Could IBRX Be A Tokenized Stock? Founder\u2019s Tease Sends ImmunityBio Traders Into Speculation Mode ImmunityBio (IBRX) shares saw a surge after founder Patrick Soon-Shiong hinted at Nant's upcoming venture into blockchain-based stock trading, leading to speculation among retail traders that IBRX could become a tokenized stock.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.54, "provider_directional_mass": 0.4914, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.1e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 25.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 3, "topics": ["Blockchain", "Financial Markets", "Life Sciences", "Technology"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales \u2013 IBRX Stock Gains 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPX1JLaG1ySTUyYjBBMy1nNkNZZWtGSHRUQlRMcWZ6MW8yczZ2NTZvNlkxTGNFNjlFeEoyX2pTNi12anNlMWJNOHpLaXphY21KcFpZdW1kVU56MkhGMjN1eGtuMXpJbnJ0YTZRWkc3OFRYdHlpeWRYYWpzTU5acUFZYVBTZm1SWmdXLWw4ejFMNjE1aG9vRDE4X0ZienBYbF9xSVJRbDZmU0E3LUdDM2FNMjF3?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T21:30:44+00:00", "published_display": "19 Sep 2026 21:30", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "fa5e19a21e2a8ac68ebcb7c32b4157d3c035ce7f017d95ed01aa2ffa74535fed", "target_scope": "ImmunityBio\u2019s Q4 Revenue Gets A Lift From ANKTIVA Sales IBRX Stock Gains 11%", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003187, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 2.5, "age_days": 26.7, "influence_label": "Low", "evidence_strength": 32, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPenU3dWxnUEJNNGZoVEJDQVpCb0huYUVUSHczNWhMdVRROTUyN1ZjQ0NoVzRRcUpFRHZTNjhoSDV3VFdKbDIyZDg4dHVqU2RVV1dnR0hCeEFNRno4WWNyS21ZSzcwWmg3bEZIRDVwQVQ5UUNmaDlNaEFqa1Rpa0oxR0ItZ1dtcXBTb2J1WnYzcE15N3g4RFlvUkxDRldmTi1nRnpsNUZaam5OREFCM1AxM3pkSXRBR19yWmhjcmI5OG95R1llUmZnUkVLSmNzTFJubEl6V1hUREJ6ZnJUVEdNUXRCWHk?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T19:56:54+00:00", "published_display": "19 Sep 2026 19:56", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "93646f378673495c969cef8244a27b83b816e64a7a4a0e98a1d675d0f3f1cd6f", "target_scope": "IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva\u2019s Blowout Growth", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.7250000000000001, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Positive analyst conviction", "Positive market reaction"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000402, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 0.2, "age_days": 26.8, "influence_label": "Medium", "evidence_strength": 45, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "IBRX Stock Eyes Green Open Ahead Of Earnings \u2014 What Happened With Anktiva Over The Weekend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPTUgwX00tMVFLcUhkQmVXR3YtWkdCekY5eDBieEU1YWtYcjB0SHdMbWlad0hqdnVZUkJiNE96cWFaT3ktYTVhaUtUbnBGM253eF8xSWlRSVpKdHlRUEFkU0FGd0NXQjJvUlk5LUI3NUVRZWtlZHZfaXhJUXRLUDViQTFKZHdUa09OQ1N2YV9tSUxNaDF1U0JCQmZUWDZ5OTdiUHVfTXQ5MGVWempuNXJMX010ekhhZGZvVVlWNjE2Q3BUQ0x5bmU3YjYtRVJXc0FpbVMwckMyN3BXY0trX1RYNHo3dmI5cHM?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T18:33:43+00:00", "published_display": "19 Sep 2026 18:33", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "e43242b572a92458371cb7a82e4035fc2cb951ae78e17a58e6cc05efd7a048d4", "target_scope": "IBRX Stock Eyes Green Open Ahead Of Earnings", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002299, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.4, "age_days": 26.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "IBRX Stock To Open Week On A High? Chairman Teases Anktiva\u2019s 3-Year Expansion Plans, Hints At Cancer Breakthrough", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPU1hWM0R3cTRmNVEtVzJBZTA5WG1UVnRzUHp4MDdXamhITEUtOWxtUDFzektqbnBlX3U5QUFSaTVhbWlldnBHQnkzZ0wtYUt1WU9NV05QRFg2OUdxbWhpRVBWU0prODJkZkhrT1Rfb0ZacGpUVkt2MGljc1dUNnNkakl6Zks1WVhIT1NjbFRDTElCOEotWGZRUEV5UVBfU09Ca045LVZ2dmdzczlwbWg2QVVPdTdlWUxKdVNoYVRKeWZ0dmc2X3drTmJJc2tjZms0UDNmQlBOTXNmeFlyMDRodWFleEluQUp5VU8wVm15YVg?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-19T10:45:04+00:00", "published_display": "19 Sep 2026 10:45", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["IBRX.ARCHIVE"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "2edea314facb9f0af2ec361b432824e0052683a9c3d3c296d0da4ea9c7e93128", "target_scope": "IBRX Stock To Open Week On A High?", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 27.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last?", "summary": "ImmunityBio IBRX shares soared 7% in the last trading session to close at $8.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.7% loss over the past four weeks. Recently, ImmunityBio's founder and executive chairman, Dr. Patrick Soon-Shiong, through his investment vehicle Nant Capital, led an $11.3 million PIPE financing for small-cap biotech PDS Biotechnology. Alongside the financing, a Nant affiliate received a one-year exclusive right to negotiate a license for PDS0101, PDS's investigational HPV-targeted immu", "url": "https://finance.yahoo.com/markets/stocks/articles/immunitybio-ibrx-moves-7-0-074100937.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/immunitybio-ibrx-moves-7-0-074100937.html", "source_link_is_lookup": false, "source_name": "Zacks", "published_at": "2026-09-18T07:41:00+00:00", "published_display": "18 Sep 2026 07:41", "provider": "archive", "providers": ["archive", "eodhd", "google_news", "yfinance"], "provider_symbol": "IBRX.US", "provider_symbols": ["BH3.F", "IBRX", "IBRX.ARCHIVE", "IBRX.US", "PDSB", "PDSB.US", "PTCT", "PTCT.US"], "target_provider_symbol": "IBRX.ARCHIVE", "cross_listing": false, "source_names": ["Market source", "Zacks", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "15619c059fdd1d27488ae2cca4646daad23349eacec1df023a7244cf3249f131", "target_scope": "ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last? ImmunityBio IBRX shares soared 7% in the last trading session to close at $8.46. Recently, ImmunityBio's founder and executive chairman, Dr.", "durable_archive": false, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.683, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 28.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Biotech", "Earnings", "Earnings Estimate", "Immunotherapy", "Medical", "Revenue Growth"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Shareholders to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into ImmunityBio, Inc. (IBRX) for potential corporate wrongdoing. The firm encourages shareholders who purchased ImmunityBio securities before January 19, 2026, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to recover investor capital.", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1209961", "source_link": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1209961", "source_link_is_lookup": false, "source_name": "ACCESS Newswire", "published_at": "2026-09-17T21:37:55", "published_display": "17 Sep 2026 21:37", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["IBRX", "IBRX.ARCHIVE"], "target_provider_symbol": "IBRX", "cross_listing": false, "source_names": ["ACCESS Newswire"], "source_kind": "publisher", "story_key": "63065c65e06a6179749bdd9e9cccff147d8376f754c70d31c8ad6c6e96061117", "target_scope": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Shareholders to Learn More About the Investigation Bronstein, Gewirtz & Grossman, LLC has launched an investigation into ImmunityBio, Inc. (IBRX) for potential corporate wrongdoing. The firm encourages shareholders who purchased ImmunityBio securities before January 19, 2026, and still hold them, to join the investigation.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.768, "provider_directional_mass": 0.8207, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 25, "tone_signals": ["Legal or regulatory risk"], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.021628, "evidence_share": 10.2, "evidence_share_display": "10.2", "freshness_pct": 5.8, "age_days": 28.7, "influence_label": "Medium", "evidence_strength": 54, "duplicate_count": 1, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}], "industry": [], "sector": []}, "total_fetched": 61, "total_unique": 61, "total_relevant": 49, "pipeline_health": {"status": "partial", "providers_attempted": 4, "providers_with_results": 3, "raw_articles": 133, "unique_stories": 89, "duplicates_removed": 44, "relevant_stories": 49, "matched_archive_stories": 74, "current_evidence": 21, "direct_evidence": 49, "archive_articles": 32, "durable_story_count": 61, "durable_evidence_used": true, "durable_collected_at": "2026-10-07T23:19:56.716448+00:00"}, "sentiment_summary": {"positive": 17, "negative": 4, "neutral": 28, "score": 52, "raw_score": 60, "total": 61, "evidence_count": 21, "effective_articles": 4.46, "information_mass": 0.212, "direct_story_count": 49, "directional_story_count": 21, "direct_source_count": 9, "industry_story_count": 0, "sector_story_count": 0, "story_count": 49, "source_count": 9, "source_concentration": 0.4066, "direct_share": 100, "dispersion": 13, "confidence": 22, "evidence_status": "provisional", "score_version": "evidence-v11", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-10-07T03:27:39+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 17.22, "count": 28}, {"event": "earnings", "label": "Earnings", "weight": 6.6, "count": 11}, {"event": "analyst", "label": "Analyst action", "weight": 2.4, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.2, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.2, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.2, "count": 2}], "positive_events": 17, "negative_events": 4, "pipeline": {"status": "partial", "providers_attempted": 4, "providers_with_results": 3, "raw_articles": 133, "unique_stories": 89, "duplicates_removed": 44, "relevant_stories": 49, "matched_archive_stories": 74, "current_evidence": 21, "direct_evidence": 49, "archive_articles": 32, "durable_story_count": 61, "durable_evidence_used": true, "durable_collected_at": "2026-10-07T23:19:56.716448+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 10.51, "latest_week": "2026-10-09", "one_week_move": 2.2, "four_week_move": 32.9, "twelve_week_move": 36.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.814165, "market_dynamics_buy_signal": false, "relative_strength": 45.632824, "fair_value_gap": 119.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 42.6185, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.2% over one week, +32.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 22, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stocktwits", "count": 21}, {"label": "StocksToTrade", "count": 3}, {"label": "AD HOC NEWS", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "Simply Wall Street", "count": 2}, {"label": "TradingKey", "count": 2}, {"label": "The Cryptonomist", "count": 2}, {"label": "Insider Monkey", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Earnings", "count": 11}, {"label": "Analyst action", "count": 4}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "22/100", "tone": "neutral", "text": "4.46 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "13/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.2% over one week, +32.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat"}], "updated_at": "2026-10-07T23:19:56.716448+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "49 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 52, "display": "52", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 22, "display": "22", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "49 company stories"}, {"label": "Story agreement", "value": 87, "display": "87", "tone": "positive", "note": "13/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 4, "note": "0.212 after freshness weighting"}, {"label": "Source breadth", "value": 100, "note": "9 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 10, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 87, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 59, "note": "less reliance on one publisher"}], "influence": {"events": [{"label": "Balance sheet", "positive": 0.125525, "negative": 0.0, "count": 2, "positive_share": 59.3, "positive_width": 50.0, "negative_share": 0.0, "negative_width": 0.0}, {"label": "Analyst action", "positive": 0.034458, "negative": 0.0, "count": 4, "positive_share": 16.3, "positive_width": 13.726, "negative_share": 0.0, "negative_width": 0.0}, {"label": "Regulatory and legal", "positive": 0.0, "negative": 0.021628, "count": 1, "positive_share": 0.0, "positive_width": 0.0, "negative_share": 10.2, "negative_width": 8.615}, {"label": "Earnings", "positive": 0.016326, "negative": 0.0, "count": 2, "positive_share": 7.7, "positive_width": 6.503, "negative_share": 0.0, "negative_width": 0.0}, {"label": "Market update", "positive": 0.005901999999999999, "negative": 0.007789, "count": 12, "positive_share": 2.8, "positive_width": 2.351, "negative_share": 3.7, "negative_width": 3.103}], "sources": [{"label": "StocksToTrade", "weight": 0.126301, "count": 3, "share": 59.7}, {"label": "Stocktwits", "weight": 0.040341, "count": 9, "share": 19.1}, {"label": "ACCESS Newswire", "weight": 0.021628, "count": 1, "share": 10.2}, {"label": "AD HOC NEWS", "weight": 0.009937, "count": 1, "share": 4.7}, {"label": "Investing.com", "weight": 0.006796, "count": 1, "share": 3.2}, {"label": "Remaining publishers", "weight": 0.006625000000000001, "count": 6, "share": 3.1}], "directional_count": 21, "retained_count": 49, "source_count": 9, "top_share": 59.7, "axis_max": 59.3}, "freshness": 10, "source_independence": 59, "timeline": [{"date": "2026-09-17", "label": "17 Sep", "count": 1, "score": 25, "tone": "negative", "x": 42.0, "y": 180.5, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-18", "label": "18 Sep", "count": 1, "score": 55, "tone": "neutral", "x": 73.6, "y": 125.9, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-19", "label": "19 Sep", "count": 4, "score": 55, "tone": "neutral", "x": 105.2, "y": 125.9, "volume_height": 23.1, "volume_y": 242.9}, {"date": "2026-09-20", "label": "20 Sep", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-21", "label": "21 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-22", "label": "22 Sep", "count": 1, "score": 74, "tone": "positive", "x": 199.9, "y": 91.3, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-23", "label": "23 Sep", "count": 2, "score": 50, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 11.6, "volume_y": 254.4}, {"date": "2026-09-24", "label": "24 Sep", "count": 1, "score": 55, "tone": "neutral", "x": 263.1, "y": 125.9, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-25", "label": "25 Sep", "count": 1, "score": 53, "tone": "neutral", "x": 294.7, "y": 129.5, "volume_height": 5.8, "volume_y": 260.2}, {"date": "2026-09-26", "label": "26 Sep", "count": 2, "score": 50, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 11.6, "volume_y": 254.4}, {"date": "2026-09-27", "label": "27 Sep", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-28", "label": "28 Sep", "count": 2, "score": 50, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 11.6, "volume_y": 254.4}, {"date": "2026-09-29", "label": "29 Sep", "count": 3, "score": 50, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-30", "label": "30 Sep", "count": 9, "score": 57, "tone": "neutral", "x": 452.6, "y": 122.3, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-10-01", "label": "01 Oct", "count": 3, "score": 55, "tone": "neutral", "x": 484.2, "y": 125.9, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-10-02", "label": "02 Oct", "count": 7, "score": 63, "tone": "positive", "x": 515.8, "y": 111.3, "volume_height": 40.4, "volume_y": 225.6}, {"date": "2026-10-03", "label": "03 Oct", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-04", "label": "04 Oct", "count": 4, "score": 50, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 23.1, "volume_y": 242.9}, {"date": "2026-10-05", "label": "05 Oct", "count": 2, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 11.6, "volume_y": 254.4}, {"date": "2026-10-06", "label": "06 Oct", "count": 3, "score": 49, "tone": "neutral", "x": 642.1, "y": 136.8, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-10-07", "label": "07 Oct", "count": 2, "score": 69, "tone": "positive", "x": 673.7, "y": 100.4, "volume_height": 11.6, "volume_y": 254.4}, {"date": "2026-10-08", "label": "08 Oct", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-09", "label": "09 Oct", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-10", "label": "10 Oct", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-11", "label": "11 Oct", "count": 0, "score": null, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-12", "label": "12 Oct", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-13", "label": "13 Oct", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-14", "label": "14 Oct", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-15", "label": "15 Oct", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-16", "label": "16 Oct", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "42.0,180.5 73.6,125.9 105.2,125.9 168.3,135.0 199.9,91.3 231.5,135.0 263.1,125.9 294.7,129.5 326.3,135.0 389.4,135.0 421.0,135.0 452.6,122.3 484.2,125.9 515.8,111.3 579.0,135.0 610.6,135.0 642.1,136.8 673.7,100.4", "timeline_path": "M42.0,180.5 L73.6,125.9 L105.2,125.9 M168.3,135.0 L199.9,91.3 L231.5,135.0 L263.1,125.9 L294.7,129.5 L326.3,135.0 M389.4,135.0 L421.0,135.0 L452.6,122.3 L484.2,125.9 L515.8,111.3 M579.0,135.0 L610.6,135.0 L642.1,136.8 L673.7,100.4", "timeline_has_signal": true, "timeline_start": "17 Sep", "timeline_mid": "02 Oct", "timeline_end": "16 Oct", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": null, "delta": null, "recent_count": 0, "prior_count": 0, "volume_delta": 0, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": null, "delta": null, "latest_count": 0, "baseline_count": 0, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 14 days", "count": 15, "share": 31}, {"label": "15 to 21 days", "count": 22, "share": 45}, {"label": "22 to 30 days", "count": 12, "share": 24}], "source_profile": [{"label": "Stocktwits", "count": 21, "share": 43, "score": 54, "tone": "neutral"}, {"label": "StocksToTrade", "count": 3, "share": 6, "score": 64, "tone": "positive"}, {"label": "The Cryptonomist", "count": 2, "share": 4, "score": 64, "tone": "positive"}, {"label": "AD HOC NEWS", "count": 2, "share": 4, "score": 56, "tone": "neutral"}, {"label": "Insider Monkey", "count": 2, "share": 4, "score": 55, "tone": "neutral"}, {"label": "TradingKey", "count": 2, "share": 4, "score": 52, "tone": "neutral"}, {"label": "Stock Titan", "count": 2, "share": 4, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Market update", "count": 28, "share": 57, "score": 50, "tone": "neutral"}, {"label": "Earnings", "count": 11, "share": 22, "score": 52, "tone": "neutral"}, {"label": "Analyst action", "count": 4, "share": 8, "score": 70, "tone": "positive"}, {"label": "Balance sheet", "count": 2, "share": 4, "score": 64, "tone": "positive"}, {"label": "Regulatory and legal", "count": 2, "share": 4, "score": 41, "tone": "negative"}, {"label": "Guidance", "count": 2, "share": 4, "score": 50, "tone": "neutral"}], "topics": [{"label": "Life Sciences", "count": 23, "share": 47}, {"label": "Financial Markets", "count": 21, "share": 43}, {"label": "Earnings", "count": 11, "share": 22}, {"label": "Finance", "count": 5, "share": 10}, {"label": "Immunotherapy", "count": 2, "share": 4}, {"label": "Blockchain", "count": 2, "share": 4}, {"label": "Biotech", "count": 2, "share": 4}, {"label": "Technology", "count": 1, "share": 2}, {"label": "Revenue Growth", "count": 1, "share": 2}, {"label": "Medical", "count": 1, "share": 2}], "supporting": [{"label": "Direct evidence", "text": "49 current stories are mapped specifically to IBRX."}, {"label": "Source breadth", "text": "The score uses 9 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.212."}, {"label": "Confidence", "text": "Confidence is 22/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "IBRX Stock Extends 5-Day Losing Streak \u2014 Retail Traders Pin Hopes On \u2018Incredibly Strong\u2019 Anktiva Sales And Earnings Beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSWE3ZUdoYjhhUlNXdmFpNlpidkVrVWlmcTBQcU0tRnJDZ1gwUnpEeHJwT0NzRElEblB1YVFocXE2aXNGdFotRFRHOHNGMmNXVEJUdXFpR2EzRlUxYnpUTHJtd3V5ZXRfOTk0NHVHem1LMk9pNTd6dXVQSmFEeVE4OER0dzBYVV9JRjJ2Y0hMQjBQb25NOWRuaExGZzd6bHFBMXhZeEtZWWgzZVVFWmtR?oc=5", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-10-07T03:27:39+00:00", "published_display": "07 Oct 2026 03:27", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Beat expectations"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002225, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.8, "age_days": 9.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, "article_count": 49, "updated_at": "2026-10-07T23:19:56.716448+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 172.0, "label": "17 Apr 2026", "close": 7.7, "index": 100.0}, {"x": 78.4, "y": 182.7, "label": "24 Apr 2026", "close": 7.44, "index": 96.6}, {"x": 114.9, "y": 196.3, "label": "01 May 2026", "close": 7.11, "index": 92.3}, {"x": 151.3, "y": 138.5, "label": "08 May 2026", "close": 8.51, "index": 110.5}, {"x": 187.7, "y": 160.8, "label": "15 May 2026", "close": 7.97, "index": 103.5}, {"x": 224.2, "y": 191.8, "label": "22 May 2026", "close": 7.22, "index": 93.8}, {"x": 260.6, "y": 179.4, "label": "29 May 2026", "close": 7.52, "index": 97.7}, {"x": 297.0, "y": 204.2, "label": "05 Jun 2026", "close": 6.92, "index": 89.9}, {"x": 333.5, "y": 196.8, "label": "12 Jun 2026", "close": 7.1, "index": 92.2}, {"x": 369.9, "y": 186.0, "label": "19 Jun 2026", "close": 7.36, "index": 95.6}, {"x": 406.3, "y": 130.2, "label": "26 Jun 2026", "close": 8.71, "index": 113.1}, {"x": 442.8, "y": 100.0, "label": "03 Jul 2026", "close": 9.44, "index": 122.6}, {"x": 479.2, "y": 150.5, "label": "10 Jul 2026", "close": 8.22, "index": 106.8}, {"x": 515.6, "y": 172.8, "label": "17 Jul 2026", "close": 7.68, "index": 99.7}, {"x": 552.0, "y": 196.8, "label": "24 Jul 2026", "close": 7.1, "index": 92.2}, {"x": 588.5, "y": 193.9, "label": "31 Jul 2026", "close": 7.17, "index": 93.1}, {"x": 624.9, "y": 174.4, "label": "07 Aug 2026", "close": 7.64, "index": 99.2}, {"x": 661.3, "y": 177.3, "label": "14 Aug 2026", "close": 7.57, "index": 98.3}, {"x": 697.8, "y": 168.2, "label": "21 Aug 2026", "close": 7.79, "index": 101.2}, {"x": 734.2, "y": 157.5, "label": "28 Aug 2026", "close": 8.05, "index": 104.5}, {"x": 770.6, "y": 156.2, "label": "04 Sep 2026", "close": 8.08, "index": 104.9}, {"x": 807.1, "y": 163.3, "label": "11 Sep 2026", "close": 7.91, "index": 102.7}, {"x": 843.5, "y": 139.7, "label": "18 Sep 2026", "close": 8.48, "index": 110.1}, {"x": 879.9, "y": 141.4, "label": "25 Sep 2026", "close": 8.44, "index": 109.6}, {"x": 916.4, "y": 65.1, "label": "02 Oct 2026", "close": 10.285, "index": 133.6}, {"x": 952.8, "y": 55.8, "label": "09 Oct 2026", "close": 10.51, "index": 136.5}], "sentiment_points": [{"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 27, "stories": 6, "close": 8.71, "price_change": 18.3, "x": 411.5, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 15, "stories": 8, "close": 9.44, "price_change": 8.4, "x": 448.0, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 43, "confidence": 25, "stories": 12, "close": 8.22, "price_change": -12.9, "x": 484.4, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 46, "tone": "neutral", "raw_score": 35, "confidence": 32, "stories": 17, "close": 7.68, "price_change": -6.6, "x": 520.8, "y": 137.4, "show_label": true, "label_y": 127.4}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 46, "tone": "neutral", "raw_score": 38, "confidence": 33, "stories": 22, "close": 7.1, "price_change": -7.6, "x": 557.2, "y": 137.4, "show_label": false, "label_y": 127.4}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 54, "tone": "neutral", "raw_score": 57, "confidence": 45, "stories": 31, "close": 7.17, "price_change": 1.0, "x": 593.7, "y": 122.6, "show_label": false, "label_y": 112.6}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 57, "tone": "neutral", "raw_score": 61, "confidence": 49, "stories": 44, "close": 7.64, "price_change": 6.6, "x": 630.1, "y": 117.1, "show_label": true, "label_y": 107.1}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 57, "tone": "neutral", "raw_score": 62, "confidence": 38, "stories": 50, "close": 7.57, "price_change": -0.9, "x": 666.5, "y": 117.1, "show_label": false, "label_y": 107.1}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 57, "tone": "neutral", "raw_score": 64, "confidence": 35, "stories": 60, "close": 7.79, "price_change": 2.9, "x": 703.0, "y": 117.1, "show_label": false, "label_y": 107.1}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 53, "tone": "neutral", "raw_score": 56, "confidence": 36, "stories": 64, "close": 8.05, "price_change": 3.3, "x": 739.4, "y": 124.5, "show_label": true, "label_y": 114.5}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 51, "confidence": 31, "stories": 57, "close": 8.08, "price_change": 0.4, "x": 775.8, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 52, "tone": "neutral", "raw_score": 56, "confidence": 28, "stories": 56, "close": 7.91, "price_change": -2.1, "x": 812.3, "y": 126.3, "show_label": false, "label_y": 116.3}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 40, "confidence": 31, "stories": 51, "close": 8.48, "price_change": 7.2, "x": 848.7, "y": 135.5, "show_label": true, "label_y": 125.5}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 53, "tone": "neutral", "raw_score": 58, "confidence": 29, "stories": 45, "close": 8.44, "price_change": -0.5, "x": 885.1, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 59, "tone": "positive", "raw_score": 65, "confidence": 47, "stories": 58, "close": 10.285, "price_change": 21.9, "x": 921.6, "y": 113.4, "show_label": false, "label_y": 103.4}, {"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 58, "tone": "positive", "raw_score": 66, "confidence": 34, "stories": 59, "close": 10.51, "price_change": 2.2, "x": 958.0, "y": 115.3, "show_label": true, "label_y": 105.3}], "price_path": "42.0,172.0 78.4,182.7 114.9,196.3 151.3,138.5 187.7,160.8 224.2,191.8 260.6,179.4 297.0,204.2 333.5,196.8 369.9,186.0 406.3,130.2 442.8,100.0 479.2,150.5 515.6,172.8 552.0,196.8 588.5,193.9 624.9,174.4 661.3,177.3 697.8,168.2 734.2,157.5 770.6,156.2 807.1,163.3 843.5,139.7 879.9,141.4 916.4,65.1 952.8,55.8", "sentiment_path": "411.5,130.0 448.0,130.0 484.4,130.0 520.8,137.4 557.2,137.4 593.7,122.6 630.1,117.1 666.5,117.1 703.0,117.1 739.4,124.5 775.8,128.2 812.3,126.3 848.7,135.5 885.1,124.5 921.6,113.4 958.0,115.3", "score_version": "evidence-v11", "price_change": 36.5, "sentiment_change": 8, "recent_pairs": [{"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 58, "tone": "positive", "raw_score": 66, "confidence": 34, "stories": 59, "close": 10.51, "price_change": 2.2, "x": 958.0, "y": 115.3, "show_label": true, "label_y": 105.3}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 59, "tone": "positive", "raw_score": 65, "confidence": 47, "stories": 58, "close": 10.285, "price_change": 21.9, "x": 921.6, "y": 113.4, "show_label": false, "label_y": 103.4}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 53, "tone": "neutral", "raw_score": 58, "confidence": 29, "stories": 45, "close": 8.44, "price_change": -0.5, "x": 885.1, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 40, "confidence": 31, "stories": 51, "close": 8.48, "price_change": 7.2, "x": 848.7, "y": 135.5, "show_label": true, "label_y": 125.5}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 52, "tone": "neutral", "raw_score": 56, "confidence": 28, "stories": 56, "close": 7.91, "price_change": -2.1, "x": 812.3, "y": 126.3, "show_label": false, "label_y": 116.3}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 51, "confidence": 31, "stories": 57, "close": 8.08, "price_change": 0.4, "x": 775.8, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 53, "tone": "neutral", "raw_score": 56, "confidence": 36, "stories": 64, "close": 8.05, "price_change": 3.3, "x": 739.4, "y": 124.5, "show_label": true, "label_y": 114.5}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 57, "tone": "neutral", "raw_score": 64, "confidence": 35, "stories": 60, "close": 7.79, "price_change": 2.9, "x": 703.0, "y": 117.1, "show_label": false, "label_y": 107.1}], "reconstructed": true, "latest_close": 10.51, "price_observations": 26, "sentiment_observations": 16, "sentiment_start_label": "26 Jun 2026", "sentiment_end_label": "09 Oct 2026", "sentiment_history_limited": false, "price_axis_high": 142.1, "price_axis_mid": 113.2, "price_axis_low": 84.3, "start_label": "17 Apr", "mid_label": "14 Jul", "end_label": "09 Oct", "live_score_version": "evidence-v11", "comparable_to_live": true}, "sentiment_history": [{"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 14, "articles": 44, "confidence": 49, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 14, "articles": 45, "confidence": 46, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "09 Aug 23:59", "short_label": "09 Aug", "collected_at": "2026-08-09T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 14, "articles": 45, "confidence": 45, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 12, "articles": 46, "confidence": 42, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 12, "articles": 47, "confidence": 39, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 10, "articles": 49, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 2, "score_change_display": "+2", "confidence_change": 3, "article_change": 2, "tone": "neutral", "height": 14, "articles": 51, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 14, "articles": 50, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 4, "tone": "neutral", "height": 14, "articles": 54, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "positive", "height": 16, "articles": 55, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "19 Aug 23:59", "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 1, "tone": "positive", "height": 16, "articles": 56, "confidence": 42, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 2, "tone": "positive", "height": 16, "articles": 58, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 14, "articles": 60, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 2, "score_change_display": "+2", "confidence_change": 2, "article_change": 0, "tone": "positive", "height": 18, "articles": 60, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": -1, "tone": "positive", "height": 16, "articles": 59, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "24 Aug 23:59", "short_label": "24 Aug", "collected_at": "2026-08-24T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 60, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -5, "score_change_display": "-5", "confidence_change": 6, "article_change": 4, "tone": "neutral", "height": 4, "articles": 64, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "26 Aug 23:59", "short_label": "26 Aug", "collected_at": "2026-08-26T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 6, "articles": 65, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Aug 23:59", "short_label": "27 Aug", "collected_at": "2026-08-27T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 6, "articles": 66, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Aug 23:59", "short_label": "28 Aug", "collected_at": "2026-08-28T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 6, "articles": 64, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Aug 23:59", "short_label": "30 Aug", "collected_at": "2026-08-30T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 4, "articles": 62, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 62, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 4, "tone": "neutral", "height": 4, "articles": 66, "confidence": 34, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Sep 23:59", "short_label": "03 Sep", "collected_at": "2026-09-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": -7, "tone": "neutral", "height": 4, "articles": 59, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Sep 23:59", "short_label": "05 Sep", "collected_at": "2026-09-05T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 59, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "07 Sep 23:59", "short_label": "07 Sep", "collected_at": "2026-09-07T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 57, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Sep 23:59", "short_label": "10 Sep", "collected_at": "2026-09-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 57, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Sep 23:59", "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "12 Sep 23:59", "short_label": "12 Sep", "collected_at": "2026-09-12T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 55, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -3, "tone": "neutral", "height": 4, "articles": 52, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Sep 23:59", "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 54, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "16 Sep 23:59", "short_label": "16 Sep", "collected_at": "2026-09-16T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 55, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "17 Sep 23:59", "short_label": "17 Sep", "collected_at": "2026-09-17T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -5, "score_change_display": "-5", "confidence_change": 8, "article_change": -3, "tone": "neutral", "height": 8, "articles": 52, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "18 Sep 23:59", "short_label": "18 Sep", "collected_at": "2026-09-18T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 6, "articles": 51, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "19 Sep 23:59", "short_label": "19 Sep", "collected_at": "2026-09-19T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 3, "score_change_display": "+3", "confidence_change": 5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 53, "confidence": 36, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Sep 23:59", "short_label": "21 Sep", "collected_at": "2026-09-21T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": -5, "article_change": -4, "tone": "neutral", "height": 4, "articles": 49, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Sep 23:59", "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 4, "score_change_display": "+4", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 6, "articles": 49, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 49, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "24 Sep 23:59", "short_label": "24 Sep", "collected_at": "2026-09-24T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -3, "tone": "neutral", "height": 6, "articles": 46, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 6, "articles": 45, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "26 Sep 23:59", "short_label": "26 Sep", "collected_at": "2026-09-26T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 45, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Sep 23:59", "short_label": "28 Sep", "collected_at": "2026-09-28T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 4, "score_change_display": "+4", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 12, "articles": 45, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": -1, "tone": "neutral", "height": 10, "articles": 44, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 3, "score_change_display": "+3", "confidence_change": 11, "article_change": 8, "tone": "positive", "height": 16, "articles": 52, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "positive", "height": 16, "articles": 51, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 1, "score_change_display": "+1", "confidence_change": 6, "article_change": 7, "tone": "positive", "height": 18, "articles": 58, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "04 Oct 23:59", "short_label": "04 Oct", "collected_at": "2026-10-04T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 1, "tone": "positive", "height": 16, "articles": 59, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": -2, "tone": "positive", "height": 16, "articles": 57, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -2, "score_change_display": "-2", "confidence_change": 1, "article_change": 3, "tone": "neutral", "height": 12, "articles": 60, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "07 Oct 23:59", "short_label": "07 Oct", "collected_at": "2026-10-07T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 3, "score_change_display": "+3", "confidence_change": 2, "article_change": 1, "tone": "positive", "height": 18, "articles": 61, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "16 Oct 14:05", "short_label": "16 Oct", "collected_at": "2026-10-16T14:05:45.851948+00:00", "score": 54, "delta": 4, "score_change": -5, "score_change_display": "-5", "confidence_change": -17, "article_change": -12, "tone": "neutral", "height": 8, "articles": 49, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v11", "live_version": "evidence-v11", "comparable_to_live": true, "reconstructed": true, "observations": 52, "span_label": "70 days", "first_score": 57, "latest_score": 54, "net_change": -3, "net_change_display": "-3", "direction": "Broadly stable", "high_score": 59, "low_score": 46, "latest_confidence": 23, "confidence_change": -26, "latest_articles": 49, "article_change": 5, "latest_label": "16 Oct 14:05", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 14, "articles": 44, "confidence": 49, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 42.0, "y": 122.3}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 14, "articles": 45, "confidence": 46, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 60.0, "y": 122.3}, {"label": "09 Aug 23:59", "short_label": "09 Aug", "collected_at": "2026-08-09T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 14, "articles": 45, "confidence": 45, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 77.9, "y": 122.3}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 12, "articles": 46, "confidence": 42, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 95.9, "y": 124.1}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 12, "articles": 47, "confidence": 39, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 113.8, "y": 124.1}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 10, "articles": 49, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 131.8, "y": 125.9}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 2, "score_change_display": "+2", "confidence_change": 3, "article_change": 2, "tone": "neutral", "height": 14, "articles": 51, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 149.8, "y": 122.3}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 14, "articles": 50, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 167.7, "y": 122.3}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 4, "tone": "neutral", "height": 14, "articles": 54, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 185.7, "y": 122.3}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "positive", "height": 16, "articles": 55, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 203.6, "y": 120.4}, {"label": "19 Aug 23:59", "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 1, "tone": "positive", "height": 16, "articles": 56, "confidence": 42, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 221.6, "y": 120.4}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 2, "tone": "positive", "height": 16, "articles": 58, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 239.6, "y": 120.4}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 14, "articles": 60, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 257.5, "y": 122.3}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 2, "score_change_display": "+2", "confidence_change": 2, "article_change": 0, "tone": "positive", "height": 18, "articles": 60, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 275.5, "y": 118.6}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": -1, "tone": "positive", "height": 16, "articles": 59, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 293.5, "y": 120.4}, {"label": "24 Aug 23:59", "short_label": "24 Aug", "collected_at": "2026-08-24T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 60, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 311.4, "y": 122.3}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -5, "score_change_display": "-5", "confidence_change": 6, "article_change": 4, "tone": "neutral", "height": 4, "articles": 64, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 329.4, "y": 131.4}, {"label": "26 Aug 23:59", "short_label": "26 Aug", "collected_at": "2026-08-26T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 6, "articles": 65, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 347.3, "y": 129.5}, {"label": "27 Aug 23:59", "short_label": "27 Aug", "collected_at": "2026-08-27T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 6, "articles": 66, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 365.3, "y": 129.5}, {"label": "28 Aug 23:59", "short_label": "28 Aug", "collected_at": "2026-08-28T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 6, "articles": 64, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 383.3, "y": 129.5}, {"label": "30 Aug 23:59", "short_label": "30 Aug", "collected_at": "2026-08-30T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 4, "articles": 62, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 401.2, "y": 131.4}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 62, "confidence": 35, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 419.2, "y": 131.4}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 4, "tone": "neutral", "height": 4, "articles": 66, "confidence": 34, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 437.1, "y": 131.4}, {"label": "03 Sep 23:59", "short_label": "03 Sep", "collected_at": "2026-09-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": -7, "tone": "neutral", "height": 4, "articles": 59, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 455.1, "y": 133.2}, {"label": "05 Sep 23:59", "short_label": "05 Sep", "collected_at": "2026-09-05T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 59, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 473.1, "y": 133.2}, {"label": "07 Sep 23:59", "short_label": "07 Sep", "collected_at": "2026-09-07T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 57, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 491.0, "y": 133.2}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 509.0, "y": 131.4}, {"label": "10 Sep 23:59", "short_label": "10 Sep", "collected_at": "2026-09-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 57, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 526.9, "y": 131.4}, {"label": "11 Sep 23:59", "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 544.9, "y": 131.4}, {"label": "12 Sep 23:59", "short_label": "12 Sep", "collected_at": "2026-09-12T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 55, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 562.9, "y": 131.4}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -3, "tone": "neutral", "height": 4, "articles": 52, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 580.8, "y": 131.4}, {"label": "15 Sep 23:59", "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 54, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 598.8, "y": 133.2}, {"label": "16 Sep 23:59", "short_label": "16 Sep", "collected_at": "2026-09-16T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 55, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 616.7, "y": 133.2}, {"label": "17 Sep 23:59", "short_label": "17 Sep", "collected_at": "2026-09-17T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -5, "score_change_display": "-5", "confidence_change": 8, "article_change": -3, "tone": "neutral", "height": 8, "articles": 52, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 634.7, "y": 142.3}, {"label": "18 Sep 23:59", "short_label": "18 Sep", "collected_at": "2026-09-18T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 6, "articles": 51, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 652.7, "y": 140.5}, {"label": "19 Sep 23:59", "short_label": "19 Sep", "collected_at": "2026-09-19T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 3, "score_change_display": "+3", "confidence_change": 5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 53, "confidence": 36, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 670.6, "y": 135.0}, {"label": "21 Sep 23:59", "short_label": "21 Sep", "collected_at": "2026-09-21T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": -5, "article_change": -4, "tone": "neutral", "height": 4, "articles": 49, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 688.6, "y": 136.8}, {"label": "22 Sep 23:59", "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 4, "score_change_display": "+4", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 6, "articles": 49, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 706.5, "y": 129.5}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 49, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 724.5, "y": 129.5}, {"label": "24 Sep 23:59", "short_label": "24 Sep", "collected_at": "2026-09-24T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -3, "tone": "neutral", "height": 6, "articles": 46, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 742.5, "y": 129.5}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 6, "articles": 45, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 760.4, "y": 129.5}, {"label": "26 Sep 23:59", "short_label": "26 Sep", "collected_at": "2026-09-26T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 45, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 778.4, "y": 131.4}, {"label": "28 Sep 23:59", "short_label": "28 Sep", "collected_at": "2026-09-28T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 4, "score_change_display": "+4", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 12, "articles": 45, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 796.4, "y": 124.1}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": -1, "tone": "neutral", "height": 10, "articles": 44, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 814.3, "y": 125.9}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 3, "score_change_display": "+3", "confidence_change": 11, "article_change": 8, "tone": "positive", "height": 16, "articles": 52, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 832.3, "y": 120.4}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "positive", "height": 16, "articles": 51, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 850.2, "y": 120.4}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 1, "score_change_display": "+1", "confidence_change": 6, "article_change": 7, "tone": "positive", "height": 18, "articles": 58, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 868.2, "y": 118.6}, {"label": "04 Oct 23:59", "short_label": "04 Oct", "collected_at": "2026-10-04T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 1, "tone": "positive", "height": 16, "articles": 59, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 886.2, "y": 120.4}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": -2, "tone": "positive", "height": 16, "articles": 57, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 904.1, "y": 120.4}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -2, "score_change_display": "-2", "confidence_change": 1, "article_change": 3, "tone": "neutral", "height": 12, "articles": 60, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 922.1, "y": 124.1}, {"label": "07 Oct 23:59", "short_label": "07 Oct", "collected_at": "2026-10-07T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 3, "score_change_display": "+3", "confidence_change": 2, "article_change": 1, "tone": "positive", "height": 18, "articles": 61, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 940.0, "y": 118.6}, {"label": "16 Oct 14:05", "short_label": "16 Oct", "collected_at": "2026-10-16T14:05:45.851948+00:00", "score": 54, "delta": 4, "score_change": -5, "score_change_display": "-5", "confidence_change": -17, "article_change": -12, "tone": "neutral", "height": 8, "articles": 49, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 958.0, "y": 127.7}], "chart_points": "42.0,122.3 60.0,122.3 77.9,122.3 95.9,124.1 113.8,124.1 131.8,125.9 149.8,122.3 167.7,122.3 185.7,122.3 203.6,120.4 221.6,120.4 239.6,120.4 257.5,122.3 275.5,118.6 293.5,120.4 311.4,122.3 329.4,131.4 347.3,129.5 365.3,129.5 383.3,129.5 401.2,131.4 419.2,131.4 437.1,131.4 455.1,133.2 473.1,133.2 491.0,133.2 509.0,131.4 526.9,131.4 544.9,131.4 562.9,131.4 580.8,131.4 598.8,133.2 616.7,133.2 634.7,142.3 652.7,140.5 670.6,135.0 688.6,136.8 706.5,129.5 724.5,129.5 742.5,129.5 760.4,129.5 778.4,131.4 796.4,124.1 814.3,125.9 832.3,120.4 850.2,120.4 868.2,118.6 886.2,120.4 904.1,120.4 922.1,124.1 940.0,118.6 958.0,127.7", "changes": [{"label": "16 Oct 14:05", "short_label": "16 Oct", "collected_at": "2026-10-16T14:05:45.851948+00:00", "score": 54, "delta": 4, "score_change": -5, "score_change_display": "-5", "confidence_change": -17, "article_change": -12, "tone": "neutral", "height": 8, "articles": 49, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "07 Oct 23:59", "short_label": "07 Oct", "collected_at": "2026-10-07T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 3, "score_change_display": "+3", "confidence_change": 2, "article_change": 1, "tone": "positive", "height": 18, "articles": 61, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Oct 23:59", "short_label": "06 Oct", "collected_at": "2026-10-06T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -2, "score_change_display": "-2", "confidence_change": 1, "article_change": 3, "tone": "neutral", "height": 12, "articles": 60, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": -2, "tone": "positive", "height": 16, "articles": 57, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "04 Oct 23:59", "short_label": "04 Oct", "collected_at": "2026-10-04T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": -1, "score_change_display": "-1", "confidence_change": -6, "article_change": 1, "tone": "positive", "height": 16, "articles": 59, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 1, "score_change_display": "+1", "confidence_change": 6, "article_change": 7, "tone": "positive", "height": 18, "articles": 58, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "positive", "height": 16, "articles": 51, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 3, "score_change_display": "+3", "confidence_change": 11, "article_change": 8, "tone": "positive", "height": 16, "articles": 52, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}